Clinical, Payment & Pharmacy Policies
To view Superior's latest Clinical and Payment Policy news updates, please visit Superior's Provider News and Information webpage.
Please note: To see historical policy revisions to currently posted policies, please review the Revision Log included in each policy.
Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include but are not limited to policies relating to evolving medical technologies and procedures, as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice; peer-reviewed medical literature; government agency/program approval status; evidence-based guidelines and positions of leading national health professional organizations; views of physicians practicing in relevant clinical areas affected by the policy; and other available clinical information.
All policies found in the Superior HealthPlan Clinical Policy Manual apply to Superior HealthPlan members. Policies in the Superior HealthPlan Clinical Policy Manual may have either a Superior HealthPlan or a “Centene” heading. Superior HealthPlan utilizes InterQual® criteria for those medical technologies, procedures or pharmaceutical treatments for which a Superior HealthPlan clinical policy does not exist. InterQual is a nationally recognized evidence-based decision support tool. You may access the InterQual® SmartSheet(s)™ for Adult and Pediatric procedures, durable medical equipment and imaging procedures by logging into the secure provider portal or by calling Superior HealthPlan. In addition, Superior HealthPlan may from time to time delegate utilization management of specific services; in such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Clinical Policy Manuals or InterQual®criteria is payable by Superior HealthPlan.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.
Biopharmacy policies are used to help identify whether clinician administered drugs (CAD) are medically necessary. Pharmacy policies are used to help identify whether medications dispensed by pharmacies and billed through the pharmacy benefit are medically necessary. The criteria used are based on information found in generally accepted standards of medical and pharmacy practice; peer-reviewed medical literature; government agency/program approval status; evidence-based guidelines and positions of leading national health professional organizations; views of physicians practicing in relevant clinical areas affected by the policy; and other available clinical information such as but not limited to the drug package insert. Pharmacy and biopharmacy policies are reviewed and approved by the Centene Pharmacy Services Pharmacy and Theraputic (P&T) Commitee prior to use. This webpage lists biopharmacy policies for Medicaid and biopharmacy and pharmacy policies for Ambetter.
Consistent with guidance issued by Texas Medicaid for Clinician Administered Drugs (CAD) and the regulation at 42 CFR §438.210 and 42 CFR §457.1230(d), Superior HealthPlan does not use any standard for determining medical necessity that is more restrictive than what is developed by the Vendor Drug Program. For more details on the clinical policy and prior authorization requirements, please review the Outpatient Drug Services Handbook located at: https://www.tmhp.com/resources/provider-manuals/tmppm.
Superior routinely reviews the Texas Medicaid Provider Procedures Manual (TMPPM) to ensure any of our clinical policies for medical necessity are not more restrictive than what is provided for fee-for-service with regards to amount, duration and scope of service. TMPPM is regularly updated to reflect the most recent policy and procedure changes. Advanced notification of upcoming changes appear as banner messages located at the TMHP Banner Messages.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Pharmacy department.If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Pharmacy department.
Health care claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether health care services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include, but are not limited to claims processing guidelines referenced by the Centers for Medicare and Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), Current Procedural Technology guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of health care and medical necessity, and at times state-specific claims reimbursement guidance.
All policies found in the Superior HealthPlan Payment Policy Manual apply with respect to Superior HealthPlan members. Policies in the Superior HealthPlan Payment Policy Manual may have either a Superior HealthPlan or a “Centene” heading. In addition, Superior HealthPlan may from time to time employ a vendor that applies payment policies to specific services; in such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Payment Policy Manual is payable by Superior HealthPlan.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.
Effective Policies
Ambetter from Superior HealthPlan Policies
- Air Amulance (CP.MP.175) (PDF)
- ADHD Assessment and Treatment (CP.BH.124) (PDF)
- Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and Beta-Thalassemia (CP.MP.108) (PDF)
- Applied Behavioral Analysis (CP.BH.104) (PDF)
- Assisted Reproductive Technology (CP.MP.55) (PDF)
- Bone-anchored Hearing Aid (CP.MP.93) (PDF)
- Caudal or Interlaminar Epidural Steroid Injections (CP.MP.164) (PDF)
- Clinical Trials (CP.MP.94) (PDF)
- Cochlear Implant Replacements (CP.MP.14) (PDF)
- Cosmetic and Reconstructive Procedures (CP.MP.31) (PDF)
- Deep Transcranial Magnetic Stimulation For OCD (CP.BH.201) (PDF)
- IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (CP.MP.61) (PDF)
- Diaphragmatic/Phrenic Nerve Stimulation (CP.MP.203) (PDF)
- Discography (CP.MP.115) (PDF)
- Donor Lymphocyte Infusion (CP.MP.101) (PDF)
- Drugs of Abuse: Definitive Testing (CP.MP.50) (PDF)
- Durable Medical Equipment and Orthotics and Prosthetics Guidelines (CP.MP.107) (PDF)
- EEG in the Evaluation of Headache (CP.MP.155) (PDF)
- Electric Tumor Treating Fields (Optune) (CP.MP.145) (PDF)
- Experimental Technologies (CP.MP.36) (PDF)
- Facet Joint Interventions (CP.MP.171) (PDF)
- Fecal Incontinence Treatments (CP.MP.137) (PDF)
- Fertility Preservation (CP.MP.130) (PDF)
- Fetal Surgery in Utero for Prenatally Diagnosed Malformations (CP.MP.129) (PDF)
- Gastric Electrical Stimulation (CP.MP.40) (PDF)
- Gender-Affirming Procedures (CP.MP.95) (PDF)
- Heart-Lung Transplant (CP.MP.132) (PDF)
- Home Ventilators (CP.MP.184) (PDF)
- Phototherapy for Neonatal Hyperbilirubinemia (CP.MP.150) (PDF)
- Hospice Services (CP.MP.54) (PDF)
- Hyperhidrosis Treatments (CP.MP.62) (PDF)
- Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (CP.MP.180) (PDF)
- Implantable Intrathecal or Epidural Pain Pump (CP.MP.173) (PDF)
- Implantable Wireless Pulmonary Artery Pressure Monitoring (CP.MP.160) (PDF)
- Therapeutic Utilization of Inhaled Nitric Oxide (CP.MP.87) (PDF)
- Intensity-Modulated Radiotherapy (CP.MP.69) (PDF)
- Intestinal and Multivisceral Transplant (CP.MP.58) (PDF)
- Intradiscal Steroid Injections for Pain Management (CP.MP.167) (PDF)
- IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (CP.MP.61) (PDF)
- Kidney Disorders (CP.MP.227)
- Lantidra (donislecel): Allogeneic Pancreatic Islet Cellular Therapy (CP.MP.250) (PDF)
- Liposuction for Lipedema (CP.MP.244)
- Lung Transplantation (CP.MP.57) (PDF)
- Lysis of Epidural Lesions (CP.MP.116) (PDF)
- Mechanical Stretching Devices for Joint Stiffness (CP.MP.144)
- NICU Apnea Bradycardia Guidelines (CP.MP.82) (PDF)
- NICU Discharge Guidelines (CP.MP.81) (PDF)
- Neonatal Abstinence Syndrome Guidelines (CP.MP.86) (PDF)
- Neonatal Sepsis Management (CP.MP.85) (PDF)
- Nerve Blocks and Neurolysis for Pain Management (CP.MP.170) (PDF)
- Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (CP.MP.48)
- Non-myeloablative Allogeneic Stem Cell Transplants (CP.MP.141) (PDF)
- Obstetrical Home Care Programs (CP.MP.91) (PDF)
- Omisirge (omidubicel): Nicotinamide-modified allogeneic hematopoietic progenitor cell therapy (CP.MP.249) (PDF)
- Orthognathic Surgery (CP.MP.202) (PDF)
- Osteogenic Stimulation (CP.MP.194)
- Outpatient Oxygen Use (CP.MP.190) (PDF)
- Pancreas Transplantation (CP.MP.102) (PDF)
- Panniculectomy (CP.MP.109) (PDF)
- Pediatric Heart Transplant (CP.MP.138) (PDF)
- Pediatric Kidney Transplant (CP.MP.246) (PDF)
- Pediatric Liver Transplant (CP.MP.120) (PDF)
- Physical, Occupational, and Speech Therapy Services (CP.MP.49) (PDF)
- Polymerase Chain Reaction Respiratory Viral Panel Testing (CP.MP.181) (PDF)
- Posterior Tibial Nerve Stimulation for Voiding Dysfunction (CP.MP.133) (PDF)
- Proton and Neutron Beam Therapies (CP.MP.70) (PDF)
- Reduction Mammoplasty and Gynecomastia Surgery (CP.MP.51) (PDF)
- Repair of Nasal Valve Compromise (CP.MP.210) (PDF)
- Sacroiliac Joint Interventions for Pain Management (CP.MP.166) (PDF)
- Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins (CP.MP.146) (PDF)
- Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (CP.MP.165) (PDF)
- Short Inpatient Hospital Stay (TX.CP.MP.582) (PDF)
- Skin and Soft Tissue Substitutes for Chronic Wounds (CP.MP.185) (PDF)
- Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (CP.MP.117) (PDF)
- Stereotactic Body Radiation Therapy (CP.MP.22) (PDF)
- Tandem Transplant (CP.MP.162) (PDF)
- Therapy Services (PT/OT/ST) (CP.MP.49) (PDF)
- Total Artificial Heart (CP.MP.127) (PDF)
- Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (CP.MP.163) (PDF)
- Transcranial Magnetic Stimulation for Treatment Resistant Major Depression (CP.BH.200) (PDF)
- Transplant Service Documentation Requirements (CP.MP.247) (PDF)
- Trigger Point Injections for Pain Management (CP.MP.169) (PDF)
- Urinary Incontinence Devices and Treatments (CP.MP.142) (PDF)
- Vagus Nerve Stimulation (CP.MP.12) (PDF)
- Wireless Motility Capsule (CP.MP.143) (PDF)
Please Note: The date in the link name is either the most recent revision date, or the effective date of the policy if no clinically significant changes have been made since September 1, 2019. Please refer to change log for the original effective date and previous revisions to the policy.
- Abaloparatide (Tymlos) (CP.PHAR.345) (PDF)
- Abametapir (Xeglyze) (CP.PMN.253) (PDF)
- Abemaciclib (Verzenio) (CP.PHAR.355) (PDF)
- Abiraterone (Zytiga, Yonsa) (CP.PHAR.84) (PDF)
- AbobotulinumtoxinA (Dysport) (CP.PHAR.230) (PDF)
- Abrocitinib (Cibinqo) (CP.PHAR.578) (PDF)
- Acalabrutinib (Calquence) (CP.PHAR.366) (PDF)
- Aclidinium-formoterol (Duaklir Pressair) (HIM.PA.151) (PDF)
- Acyclovir Buccal Tablet (Sitavig) (CP.PMN.210) (PDF)
- Adagrasib (Krazati) (CP.PHAR.605) (PDF)
- Adefovir (Hepsera) (CP.PHAR.142) (PDF)
- Ado-Trastuzumab Emtansine (Kadcyla) (CP.PHAR.229) (PDF)
- Aducanumab-avwa (Aduhelm) (CP.PHAR.468) (PDF)
- ADAMTS13, recombinant-krhn (Adzynma) (CP.PHAR.635) (PDF)
- Afamelanotide (Scenesse) (CP.PHAR.444) (PDF)
- Afatinib (Gilotrif) (CP.PHAR.298) (PDF)
- Aflibercept (Eylea, Eylea HD), Aflibercept-yszy (Opuviz), Aflibercept-jbvf (Yesafili), Aflibercept-mrbb (Ahzantive), Aflibercept-abzv (Enzeevu), Aflibercept-ayyh (Pavblu) (CP.PHAR.184) (PDF)
- Agalsidase Beta (Fabrazyme) (CP.PHAR.158) (PDF)
- Age Limit Override (Codeine, Tramadol, Hydrocodone) (CP.PMN.138) (PDF)
- Alectinib (Alecensa) (CP.PHAR.369) (PDF)
- Alemtuzumab (Lemtrada) (CP.PHAR.243) (PDF)
- Alendronate (Binosto, Fosamax Plus D) (CP.PMN.88) (PDF)
- Alglucosidase Alfa (Lumizyme) (CP.PHAR.160) (PDF)
- Allogeneic cultured keratinocytes and dermal fibroblasts (StrataGraft) (CP.PHAR.562) (PDF)
- Allogenic processed thymus tissue-agdc (Rethymic) (CP.PHAR.563) (PDF)
- Alpelisib (Piqray, Vijoice) (CP.PHAR.430) (PDF)
- Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (CP.PHAR.94) (PDF)
- Amantadine ER (Gocovri,Osmolex ER) (CP.PMN.89) (PDF)
- Ambrisentan (Letairis) (CP.PHAR.190) (PDF)
- Amifampridine (Firdapse) (CP.PHAR.411) (PDF)
- Amikacin (Arikayce) (CP.PHAR.401) (PDF)
- Amisulpride (Barhemsys) (CP.PMN.236) (PDF)
- Amivantamab-vmjw (Rybrevant) (CP.PHAR.544) (PDF)
- Anifrolumab-fnia (Saphnelo) (CP.PHAR.551) (PDF)
- Anti-Inhibitor Coagulant Complex, Human (Feiba) (CP.PHAR.217) (PDF)
- Antithrombin III (ATryn, Thrombate III) (CP.PHAR.564) (PDF)
- Antithymocyte Globulin (Atgam, Thymoglobulin) (CP.PHAR.506) (PDF)
- Apalutamide (Erleada) (CP.PCH.45) (PDF)
- Apomorphine (Apokyn) (CP.PHAR.488) (PDF)
- Aprepitant (Aponvie, Emend, Cinvanti), Fosaprepitant (Emend for injection, Focinvez) (CP.PMN.19) (PDF)
- Arformoterol tartrate (Brovana) (CP.PMN.201) (PDF)
- Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) (CP.PHAR.290) (PDF)
- Aripiprazole Orally Disintegrating Tablet (CP.PCH.37)(PDF)
- Armodafinil (Nuvigil) (CP.PMN.35) (PDF)
- Aprocitentan (Tryvio) (CP.PHAR.676) (PDF)
- Asciminib (Scemblix) (CP.PHAR.565) (PDF)
- Asenapine (Saphris, Secuado) (CP.PMN.15) (PDF)
- Asfotase Alfa (Strensiq) (CP.PHAR.328) (PDF)
- Aspirin/Dipyridamole (Aggrenox) (CP.PMN.20) (PDF)
- Atezolizumab (Tecentriq) (CP.PHAR.235) (PDF)
- Atidarsagene autotemcel (Lenmeldy) (CP.PHAR.602) (PDF)
- Atogepant (Qulipta) (CP.PHAR.566) (PDF)
- Avacincaptad pegol (Izervay) (CP.PHAR.641) (PDF)
- Avacopan (Tavneos) (CP.PHAR.515) (PDF)
- Avalglucosidase alfa-ngpt (Nexviazyme) (CP.PHAR.521) (PDF)
- Avapritinib (Ayvakit) (CP.PHAR.454) (PDF)
- Avatrombopag (Doptelet) (CP.PHAR.130) (PDF)
- Avelumab (Bavencio) (CP.PHAR.333) (PDF)
- Axicabtagene Ciloleucel (Yescarta) (CP.PHAR.362) (PDF)
- Axitinib (Inlyta) (CP.PHAR.100) (PDF)
- Azacitidine (Onureg, Vidaza) (CP.PHAR.387) (PDF)
- Azelaic Acid (Finacea Topical Gel/Foam) (HIM.PA.119) (PDF)
- Aztreonam (Cayston) (CP.PHAR.209) (PDF)
- Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (CP.PHAR.149) (PDF)
- Baloxavir Marboxil (Xofluza) (CP.PMN.185) (PDF)
- Bedaquiline (Sirturo) (CP.PMN.212) (PDF)
- Belantamab Mafodotin-blmf (Blenrep) (CP.PHAR.469) (PDF)
- Belatacept (Nulojix) (CP.PHAR.201) (PDF)
- Belimumab (Benlysta) (CP.PHAR.88) (PDF)
- Belinostat (Beleodaq) (CP.PHAR.311) (PDF)
- Belumosudil (Rezurock) (CP.PHAR.552) (PDF)
- Belzutifan (Welireg) (CP.PHAR.553) (PDF)
- Bempedoic acid (Nexletol), bempedoic acid-ezetimibe (Nexlizet) (CP.PMN.237) (PDF)
- Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (CP.PHAR.307) (PDF)
- Benralizumab (Fasenra) (CP.PHAR.373) (PDF)
- Benznidazole (CP.PMN.90) (PDF)
- Beremagene geperpavec-svdt (Vyjuvek) (CP.PHAR.592) (PDF)
- Berdazimer (Zelsuvmi) (CP.PMN.293) (PDF)
- Berotralstat (Orladeyo) (HIM.PA.169) (PDF)
- Betaine (Cystadane) (CP.PHAR.143) (PDF)
- Betamethasone Dipropionate Spray (Sernivo) (CP.PMN.182) (PDF)
- Betibeglogene autotemcel (Zynteglo) (CP.PHAR.545) (PDF)
- Bevacizumab (Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev) (CP.PHAR.93) (PDF)
- Bexarotene (Targretin Capsules, Gel) (CP.PHAR.75) (PDF)
- Bezlotoxumab (Zinplava) (CP.PHAR.300) (PDF)
- Bimatoprost Implant (Durysta) (CP.PHAR.486) (PDF)
- Binimetinib (Mektovi) (CP.PHAR.50) (PDF)
- Biologic and Non-biologic DMARDs (HIM.PA.SP60) (PDF)
- Birch Triterpenes (Filsuvez) (CP.PHAR.669) (PDF)
- Blinatumomab (Blincyto) (CP.PHAR.312) (PDF)
- Bortezomib (Velcade) (CP.PHAR.410) (PDF)
- Bosentan (Tracleer) (CP.PHAR.191) (PDF)
- Bosutinib (Bosulif) (CP.PHAR.105) (PDF)
- Brand Name Override and Non-Formulary Medications (HIM.PA.103) (PDF)
- Brentuximab Vedotin (Adcetris) (CP.PHAR.303) (PDF)
- Brexanolone (Zulresso) (CP.PHAR.417) (PDF)
- Brexpiprazole (Rexulti) (CP.PMN.68) (PDF)
- Brexucabtagene Autoleucel (Tecartus) (CP.PHAR.472) (PDF)
- Brigatinib (Alunbrig) (CP.PHAR.342) (PDF)
- Brimonidine Tartrate (Mirvaso) (CP.PMN.192) (PDF)
- Brinzolamide/Brimonidine (Simbrinza) (HIM.PA.15) (PDF)
- Brivaracetam (Briviact) (CP.PCH.26) (PDF)
- Brolucizumab (Beovu) (CP.PHAR.445) (PDF)
- Budesonide (Eohilia, Uceris) (CP.PMN.294) (PDF)
- Budesonide (Tarpeyo) (CP.PHAR.572) (PDF)
- Buprenorphine (Subutex) (CP.PMN.82) (PDF)
- Buprenorphine Injection (Sublocade, Brixadi) (CP.PHAR.289) (PDF)
- Buprenorphine/Naloxone (Suboxone, Zubsolv) (CP.PMN.81) (PDF)
- Bupropion/Naltrexone (Contrave) (CP.PCH.12) (PDF)
- Burosumab-twza (Crysvita) (CP.PHAR.11) (PDF)
- Butorphanol Nasal Spray (HIM.PA.46) (PDF)
- C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (HIM.PA.170) (PDF)
- Cabazitaxel (Jevtana) (CP.PHAR.316) (PDF)
- Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (CP.PHAR.573) (PDF)
- Cabozantinib (Cabometyx, Cometriq) (CP.PHAR.111) (PDF)
- Calcifediol (Rayaldee) (CP.PMN.76) (PDF)
- Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (CP.PMN.181) (PDF)
- Canakinumab (Ilaris) (CP.PHAR.246) (PDF)
- Cannabidiol (Epidiolex) (CP.PMN.164) (PDF)
- Capecitabine (Xeloda) (CP.PHAR.60) (PDF)
- Capivasertib (Truqap) (CP.PHAR.663) (PDF)
- Caplacizumab-yhdp (Cablivi) (CP.PHAR.416) (PDF)
- Capmatinib (Tabrecta) (CP.PHAR.494) (PDF)
- Carbidopa/Levodopa ER Capsules (Crexont, Rytary), EnteralSuspension (Duopa), IR Tablets (Dhivy) (CP.PMN.238) (PDF)
- Carfilzomib (Kyprolis) (CP.PHAR.309) (PDF)
- Carglumic Acid (Carbaglu) (CP.PHAR.206) (PDF)
- Cariprazine (Vraylar) (CP.PMN.91) (PDF)
- Casimersen (Amondys 45) (CP.PHAR.470) (PDF)
- Celecoxib (Celebrex, Elyxyb) (CP.PMN.122) (PDF)
- Cemiplimab-rwlc (Libtayo) (CP.PHAR.397) (PDF)
- Cenegermin-bkbj (Oxervate) (CP.PMN.186) (PDF)
- Cenobamate (Xcopri) (CP.PMN.231) (PDF)
- Ceritinib (Zykadia) (CP.PHAR.349) (PDF)
- Cerliponase alfa (Brineura) (CP.PHAR.338) (PDF)
- Cetuximab (Erbitux) (CP.PHAR.317) (PDF)
- Chenodiol (Chenodal) (CP.PMN.239) (PDF)
- Chlorambucil (Leukeran) (CP.PHAR.554) (PDF)
- Chloramphenicol Sodium Succinate (CP.PHAR.388) (PDF)
- Cholic Acid (Cholbam) (CP.PHAR.390) (PDF)
- Ciclopirox Topical Solution 8% (CP.PMN.24) (PDF)
- Ciltacabtagene Autoleucel (Carvykti) (CP.PHAR.533) (PDF)
- Cinacalcet (Sensipar) (CP.PHAR.61) (PDF)
- Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (CP.PHAR.567) (PDF)
- Ciprofloxacin/Dexamethasone (Ciprodex) (CP.PMN.248) (PDF)
- Ciprofloxacin/Fluocinolone (Otovel) (CP.PMN.249) (PDF)
- Cladribine (Mavenclad) (CP.PHAR.422) (PDF)
- Clascoterone (Winlevi) (CP.PMN.257) (PDF)
- Clobazam (Onfi, Sympazan) (CP.PMN.54) (PDF)
- Colesevelam (Welchol) (CP.PMN.250) (PDF)
- CNS Stimulants (CP.PMN.92) (PDF)
- Cobimetinib (Cotellic) (CP.PHAR.380) (PDF)
- Collagenase Clostridium Histolyticum (Xiaflex) (CP.PHAR.82) (PDF)
- Colchicine (Colcrys, Lodoco) (CP.PMN.123) (PDF)
- Colonoscopy Preparation Products (CP.PCH.43) (PDF)
- Compounded Medications (CP.PMN.280) (PDF)
- Conjugated Estrogens/Bazedoxifene (Duavee) (CP.PMN.258) (PDF)
- Continuous Glucose Monitors (CP.PMN.214) (PDF)
- Copanlisib (Aliqopa) (CP.PHAR.357) (PDF)
- Corticosteroids for Ophthalmic Injection (Dextenza, Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (CP.PHAR.385) (PDF)
- Cosyntropin (Cortrosyn) (CP.PHAR.203) (PDF)
- Crisaborole (Eucrisa) (CP.PMN.110) (PDF)
- Crizanlizumab-tmca (Adakveo) (CP.PHAR.449) (PDF)
- Crizotinib (Xalkori) (CP.PHAR.90) (PDF)
- Crovalimab (PiaSky) (CP.PHAR.664) (PDF)
- Cyclosporine (Cequa, Restasis, Verkazia, Vevye) (CP.PMN.48)(PDF)
- Cysteamine ophthalmic (Cystaran, Cystadrops) (CP.PMN.130) (PDF)
- Cysteamine oral (Cystagon, Procysbi) (CP.PHAR.155) (PDF)
- Cytomegalovirus Immune Globulin (CytoGam) (CP.PHAR.277) (PDF)
- Dabrafenib (Tafinlar) (CP.PHAR.239) (PDF)
- Dacomitinib (Vizimpro) (CP.PHAR.399) (PDF)
- Daclatasvir (Daklinza) (HIM.PA.SP27) (PDF)
- Dalfampridine (Ampyra) (CP.PHAR.248) (PDF)
- Dalteparin (Fragmin) (CP.PHAR.225) (PDF)
- Danicopan (Voydeya) (CP.PHAR.665) (PDF)
- Dapsone (Aczone Gel) (CP.PCH.32) (PDF)
- Daprodustat (Jesduvroq) (CP.PHAR.628) (PDF)
- Daptomycin (Cubicin, Cubicin RF, Dapzura RT) (CP.PHAR.351) (PDF)
- Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (CP.PHAR.310) (PDF)
- Darbepoetin Alfa (Aranesp) (CP.PHAR.236) (PDF)
- Darolutamide (Nubeqa) (CP.PHAR.435) (PDF)
- Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir (Viekira Pak) (HIM.PA.SP61) (PDF)
- Dasatinib (Sprycel, Phyrago) (CP.PHAR.72) (PDF)
- Daunorubicin-cytarabine (Vyxeos) (CP.PHAR.352) (PDF)
- DaxibotulinumtoxinA-lanm (Daxxify) (CP.PHAR.651) (PDF)
- Decitabine/Cedazuridine (Inqovi) (CP.PHAR.479) (PDF)
- Deferasirox (Exjade, Jadenu) (CP.PHAR.145) (PDF)
- Deferoxamine (Desferal) (CP.PHAR.146) (PDF)
- Deflazacort (Emflaza) (CP.PHAR.331) (PDF)
- Degarelix Acetate (Firmagon) (CP.PHAR.170) (PDF)
- Delafloxacin (Baxdela) (CP.PMN.115) (PDF)
- Delandistrogene moxeparvovec-rokl (Elevidys) (CP.PHAR.593) (PDF)
- Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (CP.PHAR.58) (PDF)
- Desmopressin Acetate (DDAVP, Stimate, Nocdurna) (CP.PHAR.214)(PDF)
- Deutetrabenazine (Austedo, Austedo XR) (CP.PCH.42) (PDF)
- Dexrazoxane (Totect) (CP.PHAR.418) (PDF)
- Dextromethorphan-bupropion (Auvelity) (CP.PMN.284) (PDF)
- Dextromethorphan-Quinidine (Nuedexta) (CP.PMN.93) (PDF)
- Diazepam (Libervant, Valtoco) (CP.PMN.216) (PDF)
- Dichlorphenamide (Keveyis) (CP.PMN.261) (PDF)
- Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (CP.PCH.28) (PDF)
- Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (CP.PHAR.249) (PDF)
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (HIM.PA.58) (PDF)
- Dolasetron (Anzemet) (CP.PMN.141) (PDF)
- Dornase alfa (Pulmozyme) (CP.PHAR.212) (PDF)
- Dostarlimab-gxly (Jemperli) (CP.PHAR.540) (PDF)
- Doxepin (Silenor, Prudoxin, Zonalon) (HIM.PA.147) (PDF)
- Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) (CP.PMN.79) (PDF)
- Dupilumab (Dupixent) (HIM.PA.SP69) (PDF)
- Durvalumab (Imfinzi) (CP.PHAR.339) (PDF)
- Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (CP.PMN.128) (PDF)
- Duvelisib (Copiktra) (CP.PHAR.400) (PDF)
- Ecallantide (Kalbitor) (CP.PHAR.177) (PDF)
- Eculizumab (Soliris), Eculizumab-aeeb (Bkemv), Eculizumab-aagh (Epysqli) (CP.PHAR.97) (PDF)
- Edaravone (Radicava, Radivaca ORS) (CP.PHAR.343) (PDF)
- Efgartigimod Alfa-fcab, Efgartigimod/Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (CP.PHAR.555) (PDF)
- Efinaconazole (Jublia) (CP.PMN.25) (PDF)
- Eflornithine (Iwilfin) (CP.PHAR.670) (PDF)
- Elacestrant (Orserdu) (CP.PHAR.623) (PDF)
- Elagolix (Orilissa), elagolix-estradiol-norethindrone (Oriahnn) (CP.PHAR.136) (PDF)
- Elapegademase-lvlr (Revcovi) (CP.PHAR.419) (PDF)
- Elbasvir/Grazoprevir (Zepatier) (HIM.PA.SP62) (PDF)
- Elexacaftor/Ivacaftor/Tezacaftor; Ivacaftor (Trikafta) (CP.PHAR.440) (PDF)
- Eliglustat (Cerdelga) (CP.PHAR.153) (PDF)
- Elivaldogene Autotemcel (Skysona) (CP.PHAR.556) (PDF)
- Elosulfase Alfa (Vimizim) (CP.PHAR.162) (PDF)
- Elotuzumab (Empliciti) (CP.PHAR.308) (PDF)
- Elranatamab-bcmm (Elrexfio) (CP.PHAR.652) (PDF)
- Eltrombopag (Alvaiz, Promacta) (CP.PHAR.180) (PDF)
- Eluxadoline (Viberzi) (CP.PMN.170) (PDF)
- Emapalumab-lzsg (Gamifant) (CP.PHAR.402) (PDF)
- Emicizumab-kxwh (Hemlibra) (CP.PHAR.370) (PDF)
- Emtricitabine/Tenofovir Alafenamide (Descovy) (CP.PMN.235) (PDF)
- Enasidenib (Idhifa) (CP.PHAR.363) (PDF)
- Encorafenib (Braftovi) (CP.PHAR.127) (PDF)
- Enfortumab Vedotin-ejfv (Padcev) (CP.PHAR.455) (PDF)
- Enfuvirtide (Fuzeon) (CP.PHAR.41) (PDF)
- Enoxaparin (Lovenox) (CP.PHAR.224) (PDF)
- Entecavir (Baraclude) (HIM.PA.08) (PDF)
- Entrectinib (Rozlytrek) (CP.PHAR.441) (PDF)
- Enzalutamide (Xtandi) (CP.PHAR.106) (PDF)
- Epcoritamab-bysp (Epkinly) (CP.PHAR.634) (PDF)
- Eplontersen (Wainua) (CP.PHAR.633) (PDF)
- Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (CP.PHAR.237) (PDF)
- Epoprostenol (Flolan, Veletri) (CP.PHAR.192) (PDF)
- Eptinezumab (Vyepti) (HIM.PA.SP64) (PDF)
- Erdafitinib (Balversa) (CP.PHAR.423) (PDF)
- Erenumab-aooe (Aimovig) (HIM.PA.SP65) (PDF)
- Eribulin Mesylate (Halaven) (CP.PHAR.318) (PDF)
- Erlotinib (Tarceva) (CP.PHAR.74) (PDF)
- Erwinia Asparaginase (Rylaze) (CP.PHAR.301) (PDF)
- Esketamine (Spravato) (CP.PMN.199) (PDF)
- Estradiol Vaginal Ring (Femring) (CP.PMN.263) (PDF)
- Etelcalcetide (Parsabiv) (CP.PHAR.379) (PDF)
- Eteplirsen (Exondys 51) (CP.PHAR.288) (PDF)
- Etranacogene Dezaparvovec (Hemgenix) (CP.PHAR.580) (PDF)
- Everolimus (Afinitor, Afinitor Disperz, Zortress) (CP.PHAR.63) (PDF)
- Evinacumab-dgnb (Evkeeza) (HIM.PA.166) (PDF)
- Evolocumab (Repatha) (HIM.PA.156) (PDF)
- Exagamglogene autotemcel (Casgevy) (CP.PHAR.603) (PDF)
- Factor IX (Human, Recombinant) (CP.PHAR.218) (PDF)
- Factor IX Complex, Human (Profilnine) (CP.PHAR.219) (PDF)
- Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (CP.PHAR.220) (PDF)
- Factor VIII (Human, Recombinant) (CP.PHAR.215) (PDF)
- Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (CP.PHAR.216) (PDF)
- Factor XIIIa_Recombinant (Tretten) (CP.PHAR.222) (PDF)
- Factor XIII Human (Corifact) (CP.PHAR.221) (PDF)
- Fam-trastuzumab Deruxtecan-nxki (Enhertu) (CP.PHAR.456) (PDF)
- Febuxostat (Uloric) (CP.PMN.57) (PDF)
- Fecal microbiota, live-jslm (Rebyota) (CP.PHAR.613) (PDF)
- Fecal microbiota spores, live-brpk (Vowst) (CP.PHAR.632) (PDF)
- Fedratinib (Inrebic) (CP.PHAR.442) (PDF)
- Faricimab-svoa (Vabysmo) (CP.PHAR.581) (PDF)
- Fenfluramine (Fintepla) (CP.PMN.246) (PDF)
- Fentanyl IR (Actiq, Fentora, Lazanda, Subsys) (CP.PMN.127) (PDF)
- Ferric Carboxymaltose (Injectafer) (CP.PHAR.234) (PDF)
- Ferric Derisomaltose (Monoferric) (CP.PHAR.480) (PDF)
- Ferric Maltol (Accrufer) (CP.PMN.213) (PDF)
- Ferric Pyrophosphate (Triferic, Triferic Avnu) (CP.PHAR.624) (PDF)
- Ferumoxytol (Feraheme) (CP.PHAR.165) (PDF)
- Fezolinetant (Veozah) (CP.PMN.289) (PDF)
- Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (CP.PHAR.526) (PDF)
- Fidanacogene Elaparvovec-dzkt (Beqvez) (CP.PHAR.643) (PDF)
- Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix), Filgrastim-aafi (Nivestym), Filgrastim-ayow (Releuko), Filgrastim-txid (Nypozi) (CP.PHAR.297) (PDF)
- Flibanserin (Addyi) (CP.PHAR.446) (PDF)
- Finerenone (Kerendia) (CP.PMN.266) (PDF)
- Fingolimod (Gilenya, Tascenso ODT) (CP.PCH.38) (PDF)
- Fluorouracil Cream (Tolak) (CP.PMN.165) (PDF)
- Fluticasone Propionate (Xhance) (CP.PMN.95) (PDF)
- Fondaparinux (Arixtra) (CP.PHAR.226) (PDF)
- Fostemsavir (Rukobia) (CP.PHAR.516) (PDF)
- Fosdenopterin (Nulibry) (CP.PHAR.471) (PDF)
- Fostamatinib (Tavalisse) (CP.PHAR.24) (PDF)
- Fremanezumab-vfrm (Ajovy) (HIM.PA.SP66) (PDF)
- Fruquintinib (Fruzaqla) (CP.PHAR.666) (PDF)
- Fulvestrant (Faslodex Injection) (CP.PHAR.424) (PDF)
- Furosemide (Furoscix) (CP.PHAR.608) (PDF)
- Futibatinib (Lytgobi) (CP.PHAR.604) (PDF)
- Gabapentin ER (Gralise, Horizant) (CP.PMN.240) (PDF)
- Galcanezumab-gnlm (Emgality) (HIM.PA.SP67) (PDF)
- Galsulfase (Naglazyme) (CP.PHAR.161) (PDF)
- Ganaxolone (Ztalmy) (CP.PMN.278) (PDF)
- Gefitinib (Iressa) (CP.PHAR.68) (PDF)
- Gemtuzumab Ozogamicin (Mylotarg) (CP.PHAR.358) (PDF)
- Gepirone (Exxua) (CP.PMN.292) (PDF)
- Gilteritinib (Xospata) (CP.PHAR.412) (PDF)
- Givosiran (Givlaari) (CP.PHAR.457) (PDF)
- Givinostat (Duvyzat) (CP.PHAR.644) (PDF)
- Glaucoma Agents (Iyuzeh, Omlonti, Rhopressa, Rocklatan, Vyzulta) (CP.PMN.286) (PDF)
- Glasdegib (Daurismo) (CP.PHAR.413) (PDF)
- Glatiramer (Copaxone, Glatopa) (HIM.PA.SP68) (PDF)
- Glatiramer Acetate (Copaxone, Glatopa) (CP.PHAR.252) (PDF)
- Glecaprevir/Pibrentasvir (Mavyret) (HIM.PA.SP36) (PDF)
- Glofitamab-gxbm (Columvi) (CP.PHAR.636) (PDF)
- Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists (HIM.PA.53) (PDF)
- Glycerol Phenylbutyrate (Ravicti) (CP.PHAR.207) (PDF)
- Golodirsen (Vyondys 53) (CP.PHAR.453) (PDF)
- Goserelin Acetate (Zoladex) (CP.PHAR.171) (PDF)
- Granisetron (Sancuso, Sustol) (CP.PMN.74) (PDF)
- Halcinonide (Halog) (HIM.PA.20) (PDF)
- Halobetasol Propionate (Bryhali, Lexette, Ultravate)(CP.PMN.180) (PDF)
- Halobetasol-Tazarotene (Duobrii) (CP.PMN.208) (PDF)
- Hemin (Panhematin) (CP.PHAR.181) (PDF)
- Histrelin Acetate (Vantas, Supprelin LA) (CP.PHAR.172) (PDF)
- House Dust Mite Allergen Extract (Odactra) (CP.PMN.111) (PDF)
- Human Growth Hormone (Somapacitan, Somatrogon, Somatropin, Lonapegsomatropin-tcgd) (HIM.PA.161) (PDF)
- Hyaluronate Derivatives (CP.PHAR.05) (PDF)
- Hydroxyprogesterone Caproate (Makena/compound) (CP.PHAR.14) (PDF)
- Hydroxyurea (Siklos, Xromi) (CP.PMN.193) (PDF)
- Ibalizumab-uiyk (Trogarzo) (CP.PHAR.378) (PDF)
- Ibandronate Injection (Boniva) (CP.PHAR.189) (PDF)
- Ibrutinib (Imbruvica) (CP.PHAR.126) (PDF)
- Ibuprofen/Famotidine (Duexis) (CP.PMN.120) (PDF)
- Icatibant (Firazyr) (CP.PHAR.178) (PDF)
- Icosapent Ethyl (Vascepa) (CP.PMN.187) (PDF)
- Idecabtagene Vicleucel (Abecma) (CP.PHAR.481) (PDF)
- Idelalisib (Zydelig) (CP.PHAR.133) (PDF)
- Idursulfase (Elaprase) (CP.PHAR.156) (PDF)
- Iloperidone (Fanapt) (CP.PMN.32) (PDF)
- Iloprost (Ventavis) (CP.PHAR.193) (PDF)
- Imatinib (Gleevec) (CP.PHAR.65) (PDF)
- Imiglucerase (Cerezyme) (CP.PHAR.154) (PDF)
- Immune Globulins (CP.PHAR.103) (PDF)
- Inclisiran (Leqvio) (CP.PHAR.568) (PDF)
- IncobotulinumtoxinA (Xeomin) (CP.PHAR.231) (PDF)
- Indacaterol (Arcapta Neohaler) (CP.PMN.203) (PDF)
- Inebilizumab-cdon (Uplizna) (CP.PHAR.458) (PDF)
- Infertility and Fertility Preservation (CP.PHAR.131) (PDF)
- Infigratinib (Truseltiq) (CP.PHAR.547) (PDF)
- Inhaled Agents for Asthma and COPD (HIM.PA.153) (PDF)
- Inotersen (Tegsedi) (CP.PHAR.405) (PDF)
- Inotuzumab Ozogamicin (Besponsa) (CP.PHAR.359) (PDF)
- Insulin Glargine (Rezvoglar, Semglee, Toujeo) (HIM.PA.09) (PDF)
- Insulin Delivery Systems (V-Go, Omnipod, InPen) (CP.PHAR.534) (PDF)
- Insulin detemir (Levemir) (HIM.PA.171) (PDF)
- Interferon beta-1a (Avonex, Rebif) (CP.PHAR.255) (PDF)
- Interferon Beta-1b (Betaseron, Extavia) (CP.PCH.46) (PDF)
- Interferon Gamma- 1b (Actimmune) (CP.PHAR.52) (PDF)
- Iobenguane I 131 (Azedra) (CP.PHAR.459) (PDF)
- Ipilimumab (Yervoy) (CP.PHAR.319) (PDF)
- Iptacopan (Fabhalta) (CP.PHAR.656) (PDF)
- Irinotecan Liposome (Onivyde) (CP.PHAR.304) (PDF)
- Isatuximab-irfc (Sarclisa) (CP.PHAR.482) (PDF)
- Isavuconazonium (Cresemba) (CP.PMN.154) (PDF)
- Isotretinoin (Absorica, Absorica LD, Amnesteem, Claravis, Myorisan, Zenatane) (CP.PMN.143) (PDF)
- Istradefylline (Nourianz) (CP.PMN.217) (PDF)
- Itraconazole (Sporanox, Tolsura) (CP.PMN.124) (PDF)
- Ivabradine (Corlanor) (CP.PMN.70) (PDF)
- Ivacaftor (Kalydeco) (CP.PHAR.210) (PDF)
- Ivermectin (Stromectol, Sklice) (CP.PMN.269) (PDF)
- Ivosidenib (Tibsovo) (CP.PHAR.137) (PDF)
- Ixazomib (Ninlaro) (CP.PHAR.302) (PDF)
- Ketamine (Ketalar) (CP.PMN.296) (PDF)
- Ketorolac Nasal Spray (Sprix) (CP.PMN.282) (PDF)
- Lecanemab-irmb (Leqembi) (CP.PHAR.596) (PDF)
- Lactic Acid/Citric Acid/Potassium Bitartrate (Phexxi) (CP.PMN.251) (PDF)
- Lanadelumab-fylo (Takhzyro) (HIM.PA.172) (PDF)
- Lanreotide (Somatuline Depot and Unbranded) (CP.PHAR.391) (PDF)
- Lapatinib (Tykerb) (CP.PHAR.79) (PDF)
- Laronidase (Aldurazyme) (CP.PHAR.152) (PDF)
- Larotrectinib (Vitrakvi) (CP.PHAR.414) (PDF)
- Lasmiditan (Reyvow) (CP.PMN.218) (PDF)
- Ledipasvir/Sofosbuvir (Harvoni) (HIM.PA.SP3) (PDF)
- Lefamulin (Xenleta) (CP.PMN.219) (PDF)
- Lenacapavir (Sunlenca) (CP.PHAR.622) (PDF)
- Lenalidomide (Revlimid) (CP.PHAR.71) (PDF)
- Lenvatinib (Lenvima) (CP.PHAR.138) (PDF)
- Leniolisib (Joenja) (CP.PHAR.597) (PDF)
- Letermovir (Prevymis) (CP.PHAR.367) (PDF)
- Leucovorin Injection (CP.PHAR.393) (PDF)
- Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (CP.PHAR.173) PDF)
- Levodopa Inhalation Powder (Inbrija) (CP.PMN.267) (PDF)
- Levoketoconazole (Recorlev) (CP.PMN.275) (PDF)
- Levoleucovorin (Fusilev, Khapzory) (CP.PHAR.151) (PDF)
- Levomilnacipran (Fetzima) (HIM.PA.125) (PDF)
- L-glutamine (Endari) (CP.PMN.116) (PDF)
- Lidocaine Transdermal (Lidoderm, ZTlido) (CP.PMN.08) (PDF)
- Lifitegrast (Xiidra) (CP.PMN.73) (PDF)
- Lifileucel (Amtagvi) (CP.PHAR.598) (PDF)
- Linezolid (Zyvox) (CP.PMN.27) (PDF)
- Lisocabtagene maraleucel (Breyanzi) (CP.PHAR.483) (PDF)
- Lofexidine (Lucemyra) (CP.PMN.152) (PDF)
- Lomustine (Gleostine) (CP.PHAR.507) (PDF)
- Lonafarnib (Zokinvy) (CP.PHAR.499) (PDF)
- Loncastuximab tesirine-lpyl (Zynlonta) (CP.PHAR.539) (PDF)
- Lorlatinib (Lorbrena) (CP.PHAR.406) (PDF)
- Lotilaner (Xdemvy) (CP.PMN.291) (PDF)
- Loteprednol etabonate (Eysuvis) (CP.PMN.260) (PDF)
- Lovotibeglogene Autotemcel (Lyfgenia) (CP.PHAR.627) (PDF)
- Lubiprostone (Amitiza) (CP.PMN.142) (PDF)
- Luliconazole Cream (Luzu) (CP.PMN.166) (PDF)
- Lumacaftor-ivacaftor (Orkambi) (CP.PHAR.213) (PDF)
- Lumasiran (Oxlumo) (CP.PHAR.473) (PDF)
- Lumateperone (Caplyta) (CP.PMN.232) (PDF)
- Lurasidone (Latuda) (CP.PMN.50) (PDF)
- Lurbinectedin (Zepzelca) (CP.PHAR.500) (PDF)
- Luspatercept-aamt (Reblozyl) (CP.PHAR.450) (PDF)
- Lusutrombopag (Mulpleta) (CP.PHAR.407)(PDF)
- Lutetium Lu 177 dotatate (Lutathera) (CP.PHAR.384) (PDF)
- Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (CP.PHAR.582) (PDF)
- Mannitol (Bronchitol) (CP.PHAR.518) (PDF)
- Maralixibat (Livmarli) (CP.PHAR.543) (PDF)
- Maribavir (Livtencity) (CP.PMN.271) (PDF)
- Margetuximab-cmkb (Margenza) (CP.PHAR.522) (PDF)
- Mavacamten (Camzyos) (CP.PMN.272) (PDF)
- Mavorixafor (Xolremdi) (CP.PHAR.679) (PDF)
- Mecamylamine (Vecamyl) (CP.PMN.136) (PDF)
- Mecasermin (Increlex) (CP.PHAR.150) (PDF)
- Mechlorethamine Gel (Valchlor) (CP.PHAR.381) (PDF)
- Macitentan (Opsumit) (CP.PHAR.194) (PDF)
- Megestrol Acetate (Megace ES) (CP.PMN.179) (PDF)
- Melphalan flufenamide (Pepaxto) (CP.PHAR.535) (PDF)
- Melphalan (Hepzato) (CP.PHAR.653) (PDF)
- Memantine ER (Namenda XR), Memantine/Donepezil (Namzaric) (CP.PCH.30) (PDF)
- Mepolizumab (Nucala) (CP.PHAR.200) (PDF)
- Mercaptopurine (Purixan) (CP.PHAR.447) (PDF)
- Metformin ER (Glumetza, Fortamet) (CP.PMN.72) (PDF)
- Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo) (CP.PHAR.134) (PDF)
- Methoxsalen (Uvadex) (HIM.PA.17) (PDF)
- Methoxy polyethylene glycol-epoetin beta (Mircera) (CP.PHAR.238) (PDF)
- Methylnaltrexone Bromide (Relistor) (CP.PMN.169) (PDF)
- Metoclopramide (Gimoti) (CP.PMN.252) (PDF)
- Metreleptin (Myalept) (CP.PHAR.425)(PDF)
- Midazolam (Nayzilam) (CP.PMN.211) (PDF)
- Midostaurin (Rydapt) (CP.PHAR.344) (PDF)
- Mifepristone (Korlym) (CP.PHAR.101) (PDF)
- Migalastat (Galafold) (CP.PHAR.394) (PDF)
- Miglustat (Zavesca) (CP.PHAR.164) (PDF)
- Milnacipran (Savella) (CP.PMN.125) (PDF)
- Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (CP.PMN.80) (PDF)
- Minocycline micronized foam (Amzeeq) (CP.PMN.242) (PDF)
- Mirvetuximab soravtansine-gynx (Elahere) (CP.PHAR.617) (PDF)
- Mitapivat (Pyrukynd) (CP.PHAR.558) (PDF)
- Mitomycin for Pyelocalyceal Solution (Jelmyto) (CP.PHAR.495) (PDF)
- Mitoxantrone (CP.PHAR.258) (PDF)
- Mobocertinib (Exkivity) (CP.PHAR.559) (PDF)
- Modafinil (Provigil) (CP.PMN.39) (PDF)
- Mogamulizumab-kpkc (Poteligeo) (CP.PHAR.139) (PDF)
- Momelotinib (Ojjaara) (CP.PHAR.654) (PDF)
- Mometasone (Asmanex) (HIM.PA.01) (PDF)
- Mometasone (Nasonex) (HIM.PA.93) (PDF)
- Mometasone Furoate (Sinuva) (CP.PHAR.448) (PDF)
- Mosunetuzumab-axgb (Lunsumio) (CP.PHAR.618) (PDF)
- Motixafortide (Aphexda) (CP.PHAR.655) (PDF)
- Moxetumomab Pasudotox-tdfk (Lumoxiti) (CP.PHAR.398) (PDF)
- Nabumetone Double-Strength (Relafen DS) (CP.PMN.287) (PDF)
- Naldemedine (Symproic) (CP.PMN.112) (PDF)
- Nadofaragene firadenovec-vncg (Adstiladrin) (CP.PHAR.461) (PDF)
- Nafarelin Acetate (Synarel) (CP.PHAR.174) (PDF)
- Nalmefene (Opvee) (CP.PHAR.638) (PDF)
- Naloxegol (Movantik) (HIM.PA.167) (PDF)
- Naltrexone (Vivitrol) (CP.PHAR.96) (PDF)
- Naproxen Oral Suspension (Naprosyn) (HIM.PA.130) (PDF)
- Naproxen/Esomeprazole (Vimovo) (CP.PMN.117) (PDF)
- Natalizumab (Tysabri), Natalizumab-sztn (Tyruko) (CP.PHAR.259) (PDF)
- Naxitamab-gqgk (Danyelza) (CP.PHAR.523) (PDF)
- Necitumumab (Portrazza) (CP.PHAR.320) (PDF)
- Nedosiran (Rivfloza) (CP.PHAR.619) (PDF)
- Neomycin/Fluocinolone Cream (Neo-Synalar) (CP.PMN.167) (PDF)
- Neratinib (Nerlynx) (CP.PHAR.365) (PDF)
- Netupitant and Palonosetron (Akynzeo), Fosnetupitant and Palonosetron (Akynzeo IV) (CP.PMN.158) (PDF)
- Nifurtimox (Lampit) (CP.PMN.256) (PDF)
- Nilotinib (Tasigna) (CP.PHAR.76) (PDF)
- Nintedanib (Ofev) (CP.PHAR.285) (PDF)
- Niraparib (Zejula) (CP.PHAR.408) (PDF)
- Nirsevimab-alip (Beyfortus) (CP.PHAR.614) (PDF)
- Nitazoxanide (Alinia) (HIM.PA.152) (PDF)
- Niraparib and Abiraterone (Akeega) (CP.PHAR.645) (PDF)
- Nirmatrelvir-Ritonavir (Paxlovid) (CP.PMN.288) (PDF)
- Nirogacestat (Ogsiveo) (CP.PHAR.671) (PDF)
- Nitisinone (Orfadin, Nityr) (CP.PHAR.132) (PDF)
- Nivolumab and Relatlimab-rmbw (Opdualag) (CP.PHAR.588) (PDF)
- Nivolumab (Opdivo) (CP.PHAR.121) (PDF)
- No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (HIM.PA.33) (PDF)
- Nogapendekin alfa inbakicept-pmln (Anktiva) (CP.PHAR.684) (PDF)
- Non-Calcium Phosphate Binders (CP.PMN.04) (PDF)
- Non-Formulary and Formulary Contraceptives (HIM.PA.100) (PDF)
- Non-Formulary Test Strips (HIM.PA.34) (PDF)
- Nusinersen (Spinraza) (CP.PHAR.327) (PDF)
- Obeticholic acid (Ocaliva) (CP.PHAR.287) (PDF)
- Obinutuzumab (Gazyva) (CP.PHAR.305) (PDF)
- Ocrelizumab (Ocrevus) (CP.PHAR.335) (PDF)
- Octreotide Acetate (Sandostatin, Sandostatin LAR, Mycapssa) (CP.PHAR.40) (PDF)
- Odevixibat (Bylvay) (CP.PHAR.528) (PDF)
- Ofatumumab (Arzerra, Kesimpta) (CP.PHAR.306) (PDF)
- Off-Label Drug Use (HIM.PA.154) (PDF)
- Olanzapine Long-Acting Injection (Zyprexa Relprevv) (CP.PHAR.292) (PDF)
- Olanzapine/Samidorphan (Lybalvi) (CP.PMN.265) (PDF)
- Olaparib (Lynparza) (CP.PHAR.360) (PDF)
- Olipudase alfa-rpcp (Xenpozyme) (CP.PHAR.586)
- Olutasidenib (Rezlidhia) (CP.PHAR.615) (PDF)
- Omadacycline (Nuzyra) (CP.PMN.188) (PDF)
- Omalizumab (Xolair) (CP.PCH.49) (PDF)
- Omaveloxolone (Skyclarys) (CP.PHAR.590) (PDF)
- Omacetaxine (Synribo) (CP.PHAR.108) (PDF)
- Omega-3-Acid Ethyl Esters (Lovaza) (CP.PMN.52) (PDF)
- OnabotulinumtoxinA (Botox) (CP.PHAR.232) (PDF)
- Onasemnogene Abeparvovec (Zolgensma) (CP.PHAR.421) (PDF)
- Ophthalmic corticosteroids (Lotemax, Durezol, Alrex, Pred Mild, FML Forte, Maxidex) (HIM.PA.03) (PDF)
- Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (CP.PHAR.536) (PDF)
- Opicapone (Ongentys) (CP.PMN.245) (PDF)
- Opioid Analgesics (HIM.PA.139) (PDF)
- Osilodrostat (Isturisa) (CP.PHAR.487) (PDF)
- Osimertinib (Tagrisso) (CP.PHAR.294) (PDF)
- Ospemifene (Osphena) (CP.PMN.168) (PDF)
- Overactive Bladder Agents (CP.PMN.198) (PDF)
- Oxymetazoline (Rhofade, Upneeq) (CP.PMN.86) (PDF)
- Ozanimod (Zeposia) (CP.PHAR.462) (PDF)
- Ozenoxacin (Xepi) (CP.PMN.119) (PDF)
- Paclitaxel protein-bound (Abraxane) (CP.PHAR.176) (PDF)
- Pacritinib (Vonjo) (CP.PHAR.583) (PDF)
- Palbociclib (Ibrance) (HIM.PA.173) (PDF)
- Paliperidone Long-Acting Injections (Invega Hafyera, InvegaSustenna, Invega Trinza, Erzofri) (CP.PHAR.291) (PDF)
- Palivizumab (Synagis) (CP.PHAR.16) (PDF)
- Palovarotene (Sohonos) (CP.PHAR.548) (PDF)
- Pancrelipase (Creon, Pancreaze, Pertyze, Viokace, Zenpep) (CP.PCH.44)
- Panitumumab (Vectibix) (CP.PHAR.321) (PDF)
- Parathyroid Hormone (Natpara) (CP.PHAR.282) (PDF)
- Paricalcitol Injection (Zemplar) (CP.PHAR.270) (PDF)
- Pasireotide (Signifor, Signifor LAR) (CP.PHAR.332) (PDF)
- Patiromer (Veltassa) (CP.PMN.205) (PDF)
- Patisiran (Onpattro) (CP.PHAR.395) (PDF)
- Pazopanib (Votrient) (CP.PHAR.81) (PDF)
- Peanut Allergen Powder-dnfp (Palforzia) (CP.PMN.220) (PDF)
- Pegaspargase (Oncaspar), Calaspargase pegol-mknl (Asparlas) (CP.PHAR.353) (PDF)
- Pegcetacoplan (Empaveli, Syfovre) (CP.PHAR.524) (PDF)
- Pegfilgrastim (Neulasta, Neulasta Onpro), Pegfilgrastimjmdb(Fulphila), Pegfilgrastim-pbbk (Fylnetra), Pegfilgrastim-apgf(Nyvepria), Eflapegrastim-xnst (Rolvedon), Efbemalenograstim alfa-vuxw(Ryzneuta), Pegfilgrastim-fpgk (Stimufend), Pegfilgrastim-cbqv (Udenyca,Udenyca Autoinjector, Udenyca Onbody), Pegfilgrastim-bmez (Ziextenzo) (CP.PHAR.296) (PDF)
- Peginterferon Alfa-2a (Pegasys) (CP.PHAR.89) (PDF)
- Peginterferon beta-1a (Plegridy) (CP.PHAR.271) (PDF)
- Pegloticase (Krystexxa) (CP.PHAR.115) (PDF)
- Pegunigalsidase alfa-iwxj (Elfabrio) (CP.PHAR.512) (PDF)
- Pegvaliase-pqpz (Palynziq) (CP.PHAR.140) (PDF)
- Pegvisomant (Somavert) (CP.PHAR.389) (PDF)
- Pembrolizumab (Keytruda) (CP.PHAR.322) (PDF)
- Pemetrexed (Alimta, Pemfexy) (CP.PHAR.368) (PDF)
- Pemigatinib (Pemazyre) (CP.PHAR.496) (PDF)
- Penicillamine (Cuprimine) (CP.PCH.09) (PDF)
- Perampanel (Fycompa) (CP.PMN.156) (PDF)
- Perfluorohexyloctane (Miebo) (CP.PMN.290) (PDF)
- Pertuzumab (Perjeta) (CP.PHAR.227) (PDF)
- Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (CP.PHAR.501) (PDF)
- Pexidartinib (Turalio) (CP.PHAR.436) (PDF)
- Phendimetrazine (CP.PCH.47) (PDF)
- Phentermine (Adipex-P, Lomaira) (CP.PCH.13) (PDF)
- Pilocarpine (Vuity, Qlosi) (CP.PMN.270) (PDF)
- Pimavanserin (Nuplazid) (CP.PMN.140) (PDF)
- Pirfenidone (Esbriet) (CP.PHAR.286) (PDF)
- Pirtobrutinib (Jaypirca) (CP.PHAR.620) (PDF)
- Pitolisant (Wakix) (CP.PMN.221) (PDF)
- Plasminogen, human-tvmh (Ryplazim) (CP.PHAR.513) (PDF)
- Plecanatide (Trulance) (CP.PMN.87) (PDF)
- Plerixafor (Mozobil) (CP.PHAR.323) (PDF)
- Polatuzumab vedotin-piiq (Polivy) (CP.PHAR.433) (PDF)
- Pomalidomide (Pomalyst) (CP.PHAR.116) (PDF)
- Ponatinib (Iclusig) (CP.PHAR.112) (PDF)
- Ponesimod (Ponvory) (CP.PHAR.537) (PDF)
- Potassium Chloride for Oral Solution (Klor-Con Powder) (HIM.PA.143) (PDF)
- Pozelimab-bbfg (Veopoz) (CP.PHAR.626) (PDF)
- Pralatrexate (Folotyn) (CP.PHAR.313) (PDF)
- Pralsetinib (Gavreto) (CP.PHAR.514) (PDF)
- Pramlintide (Symlin) (CP.PMN.129) (PDF)
- Prasterone (Intrarosa) (CP.PMN.99) (PDF)
- Pregabalin (Lyrica, Lyrica CR) (CP.PMN.33) (PDF)
- Pretomanid (CP.PMN.222) (PDF)
- Progesterone (Crinone, Endometrin) (CP.PMN.243) (PDF)
- Propranolol HCl Oral Solution (Hemangeol) (CP.PMN.58) (PDF)
- Propranolol HCl Oral Solution (Hemangeol) (CP.PCH.51) (PDF)
- Protein C Concentrate Human (Ceprotin) (CP.PHAR.330) (PDF)
- Prucalopride (Motegrity) (HIM.PA.159) (PDF)
- Pyrimethamine (Daraprim) (CP.PMN.44) (PDF)
- Quantity Limit Override and Dose Optimization (CP.PMN.59) (PDF)
- Quetiapine Extended-Release (Seroquel XR) (CP.PMN.64) (PDF)
- Quinine Sulfate (Qualaquin) (CP.PMN.262) (PDF)
- Quizartinib (Vanflyta) (CP.PHAR.646) (PDF)
- Ramucirumab (Cyramza) (CP.PHAR.119) (PDF)
- Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) (CP.PHAR.186) (PDF)
- Rasagiline (Azilect) (HIM.PA.89) (PDF)
- Ravulizumab-cwvz (Ultomiris) (CP.PHAR.415) (PDF)
- Regorafenib (Stivarga) (CP.PHAR.107) (PDF)
- Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (CP.PHAR.529) (PDF)
- Repotrectinib (Augtyro) (CP.PHAR.667) (PDF)
- Reslizumab (Cinqair) (CP.PHAR.223) (PDF)
- Resmetirom (Rezdiffra) (CP.PHAR.647) (PDF)
- Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (HIM.PA.168) (PDF)
- Respiratory Syncytial Virus Vaccine (Abrysvo) (CP.PHAR.658) (PDF)
- Retifanlimab-dlwr (Zynyz) (CP.PHAR.629) (PDF)
- Ribavirin (Rebetol, Ribasphere RibaPak) (CP.PHAR.141) (PDF)
- Ribociclib (Kisqali), Ribociclib/Letrozole (Kisqali Femara) (CP.PHAR.334) (PDF)
- Rifabutin (Mycobutin) (CP.PMN.223) (PDF)
- Rifamycin (Aemcolo) (CP.PMN.196) (PDF)
- Rifaximin (Xifaxan) (CP.PMN.47) (PDF)
- Rilonacept (Arcalyst) (CP.PHAR.266) (PDF)
- RimabotulinumtoxinB (Myobloc) (CP.PHAR.233) (PDF)
- Rimegepant (Nurtec ODT) (CP.PHAR.490) (PDF)
- Riociguat (Adempas) (CP.PHAR.195) (PDF)
- Ripretinib (Qinlock) (CP.PHAR.502) (PDF)
- Risdiplam (Evrysdi) (CP.PHAR.477) (PDF)
- Risedronate (Actonel, Atelvia) (CP.PMN.100) (PDF)
- Risperidone Long-Acting Injection (Perseris, Risperdal Consta, Rykindo, Uzedy) (CP.PHAR.293) (PDF)
- Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (CP.PHAR.260)(PDF)
- Rolapitant (Varubi) (CP.PMN.102) (PDF)
- Roflumilast (Daliresp, Zoryve) (CP.PMN.46) (PDF)
- Romidepsin (Istodax) (CP.PHAR.314) (PDF)
- Romiplostim (Nplate) (CP.PHAR.179) (PDF)
- Romosozumab-aqqg (Evenity) (CP.PHAR.428) (PDF)
- Ropeginterferon alfa-2b-njft (Besremi) (CP.PHAR.570) (PDF)
- Rozanolixizumab-noli (Rystiggo) (CP.PHAR.648) (PDF)
- Rucaparib (Rubraca) (CP.PHAR.350) (PDF)
- Rufinamide (Banzel) (CP.PMN.157) (PDF)
- Ruxolitinib (Jakafi, Opzelura) (CP.PHAR.98) (PDF)
- Sacituzumab govitecan-hziy (Trodelvy) (CP.PHAR.475) (PDF)
- Sacubitril/Valsartan (Entresto) (CP.PCH.52) (PDF)
- Safinamide (Xadago) (CP.PMN.113) (PDF)
- Sapropterin Dihydrochloride (Kuvan) (CP.PHAR.43) (PDF)
- Sarecycline (Seysara) (CP.PMN.189) (PDF)
- Sargramostim (Leukine) (CP.PHAR.295)(PDF)
- Satralizumab-mwge (Enspryng) (CP.PHAR.463) (PDF)
- Sebelipase Alfa (Kanuma) (CP.PHAR.159) (PDF)
- Secnidazole (Solosec) (CP.PMN.103) (PDF)
- Selexipag (Uptravi) (CP.PHAR.196) (PDF)
- Selinexor (Xpovio) (CP.PHAR.431) (PDF)
- Selpercatinib (Retevmo) (CP.PHAR.478) (PDF)
- Selumetinib (Koselugo) (CP.PHAR.464) (PDF)
- Semaglutide (Wegovy) (CP.PMN.295) (PDF)
- Setmelanotide (Imcivree) (CP.PHAR.491) (PDF)
- Sildenafil (Revatio, Liqrev) (CP.PHAR.197) (PDF)
- Sildenafil for ED (Viagra) (CP.PCH.07) (PDF)
- Siltuximab (Sylvant) (CP.PHAR.329) (PDF)
- Siponimod (Mayzent) (CP.PHAR.427) (PDF)
- Sipuleucel-T (Provenge) (CP.PHAR.120) (PDF)
- Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (CP.PHAR.574) (PDF)
- Short Ragweed Pollen Allergen Extract (Ragwitek) (CP.PMN.83) (PDF)
- Sodium Oxybate (Xyrem, Lumryz) and Calcium, Magnesium, Potassium, and Sodium Oxybate (Xywav) (CP.PMN.42) (PDF)
- Sodium phenylbutyrate (Buphenyl, Pheburane, Olpruva) (CP.PHAR.208) (PDF)
- Sodium Phenylbutyrate/Taurursodiol (Relyvrio) (CP.PHAR.584) (PDF)
- Sodium thiosulfate (Pedmark) (CP.PHAR.610) (PDF)
- Sodium zirconium cyclosilicate (Lokelma) (CP.PMN.163) (PDF)
- Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors (HIM.PA.91) (PDF)
- Sofosbuvir (Sovaldi) (HIM.PA.SP2) (PDF)
- Sofosbuvir/Velpatasvir (Epclusa) (HIM.PA.SP1) (PDF)
- Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (HIM.PA.SP63) (PDF)
- Solriamfetol (Sunosi) (CP.PMN.209) (PDF)
- Sonidegib (Odomzo) (CP.PHAR.272) (PDF)
- Sorafenib (Nexavar) (CP.PHAR.69) (PDF)
- Sotatercept (Winrevair) (CP.PHAR.657) (PDF)
- Sotorasib (Lumakras) (CP.PHAR.549) (PDF)
- Sparsentan (Filspari) (CP.PHAR.631) (PDF)
- Spesolimab-sbzo (Spevigo) (CP.PHAR.606) (PDF)
- Spinosad (Natroba) (HIM.PA.134) (PDF)
- Step Therapy (HIM.PA.109) (PDF)
- Stiripentol (Diacomit) (CP.PMN.184) (PDF)
- Sunitinib (Sutent) (CP.PHAR.73) (PDF)
- Sutimlimab-jome (Enjaymo) (CP.PHAR.503) (PDF)
- Suvorexant (Belsomra) (CP.PMN.109) (PDF)
- Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract (Oralair) (CP.PMN.85) (PDF)
- Tadalafil (Adcirca, Alyq, Tadliq) (CP.PHAR.198) (PDF)
- Tadalafil BPH - ED (Cialis, Chewtadzy) (CP.PMN.132) (PDF)
- Tafamidis (Vyndaqel, Vyndamax) (CP.PHAR.432) (PDF)
- Tafasitamab-cxix (Monjuvi) (CP.PHAR.508) (PDF)
- Talazoparib (Talzenna) (CP.PHAR.409) (PDF)
- Taliglucerase alfa (Elelyso) (CP.PHAR.157) (PDF)
- Talimogene laherepvec (Imlygic) (CP.PHAR.542) (PDF)
- Talquetamab-tgvs (Talvey) (CP.PHAR.649) (PDF)
- Tapinarof (Vtama) (CP.PMN.283) (PDF)
- Tazarotene (Arazlo, Fabior, Tazorac) (CP.PMN.244) (PDF)
- Tarlatamab-dlle (Imdelltra) (CP.PHAR.685) (PDF)
- Tasimelteon (Hetlioz, Hetlioz LQ) (CP.PMN.104) (PDF)
- Tavaborole (Kerydin) (CP.PMN.105) (PDF)
- Tazemetostat (Tazverik) (CP.PHAR.452) (PDF)
- Tebentafusp-tebn (Kimmtrak) (CP.PHAR.575) (PDF)
- Teclistamab-cqyv (Tecvayli) (CP.PHAR.611) (PDF)
- Tedizolid (Sivextro) (CP.PMN.62) (PDF)
- Teduglutide (Gattex) (CP.PHAR.114) (PDF)
- Tegaserod (Zelnorm) (HIM.PA.160) (PDF)
- Telotristat Ethyl (Xermelo) (CP.PHAR.337) (PDF)
- Temozolomide (Temodar) (CP.PHAR.77) (PDF)
- Temsirolimus (Torisel) (CP.PHAR.324) (PDF)
- Tenapanor (Ibsrela, Xphozah) (HIM.PA.174) (PDF)
- Tenofovir Alafenamide Fumarate (Vemlidy) (CP.PMN.268) (PDF)
- Teplizumab-mzwv (Tzield) (CP.PHAR.492) (PDF)
- Tepotinib (Tepmetko) (CP.PHAR.530) (PDF)
- Teprotumumab (Tepezza) (CP.PHAR.465) (PDF)
- Teriflunomide (Aubagio) (CP.PCH.40) (PDF)
- Teriparatide (Forteo, Bonsity) (CP.PHAR.188) (PDF)
- Tesamorelin (Egrifta SV) (CP.PHAR.109) (PDF)
- Testosterone (Androderm) (HIM.PA.87) (PDF)
- Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (CP.PHAR.354) (PDF)
- Tetrabenazine (Xenazine) (CP.PHAR.92) (PDF)
- Tezacaftor/Ivacaftor; Ivacaftor (Symdeko) (CP.PHAR.377) (PDF)
- Tezepelumab-ekko (Tezspire) (CP.PHAR.576) (PDF)
- Thalidomide (Thalomid) (CP.PHAR.78) (PDF)
- Thioguanine (Tabloid) (CP.PHAR.437) (PDF)
- Thyrotropin Alfa (Thyrogen) (CP.PHAR.95) (PDF)
- Timothy Grass Pollen Allergen Extract (Grastek) (CP.PMN.84) (PDF)
- Tiopronin Delayed-Release (Thiola EC) (CP.PCH.50) (PDF)
- Tisagenlecleucel (Kymriah) (CP.PHAR.361) (PDF)
- Tislelizumab-jsgr (Tevimbra) (CP.PHAR.687) (PDF)
- Tisotumab vedotin-tftv (Tivdak) (CP.PHAR.561) (PDF)
- Tivozanib (Fotivda) (CP.PHAR.538) (PDF)
- Tobramycin (Bethkis, Kitabis Pak, TOBI, TOBI Podhaler) (CP.PHAR.211) (PDF)
- Tofersen (Qalsody) (CP.PHAR.591) (PDF)
- Tolvaptan (Jynarque, Samsca) (CP.PHAR.27) (PDF)
- Topical Acne Treatment (HIM.PA.71) (PDF)
- Topical Immunomodulators (CP.PMN.107) (PDF)
- Topiramate Extended-Release (Qudexy XR, Trokendi XR) (CP.PMN.281) (PDF)
- Topotecan (Hycamtin) (CP.PHAR.64) (PDF)
- Toripalimab (Loqtorzi) (CP.PHAR.668) (PDF)
- Tovorafenib (Ojemda) (CP.PHAR.686) (PDF)
- Trabectedin (Yondelis) (CP.PHAR.204) (PDF)
- Tralokinumab-ldrm (Adbry) (CP.PHAR.577) (PDF)
- Trametinib (Mekinist) (CP.PHAR.240) (PDF)
- Trastuzumab Biosimilars Trastuzumab-Hyaluronidase (CP.PHAR.228) (PDF)
- Travoprost (iDose TR) (CP.PHAR.672) (PDF)
- Tremelimumab-actl (Imjudo) (CP.PHAR.612) (PDF)
- Treprostinil (Orenitram, Remodulin, Tyvaso) (CP.PHAR.199) (PDF)
- Triamcinolone ER Injection (Zilretta) (CP.PHAR.371) (PDF)
- Triclabendazole (Egaten) (CP.PMN.207) (PDF)
- Trientine (Syprine, Cuvrior) (CP.PHAR.438) (PDF)
- Trifarotene (Aklief) (CP.PMN.225) (PDF)
- Trifluridine-tipiracil (Lonsurf) (CP.PHAR.383) (PDF)
- Triheptanoin (Dojolvi) (CP.PHAR.509) (PDF)
- Triptorelin pamoate (Trelstar, Triptodur) (CP.PHAR.175) (PDF)
- Trofinetide (Daybue) (CP.PHAR.600) (PDF)
- Tucatinib (Tukysa) (CP.PHAR.497) (PDF)
- Ublituximab-xiiy (Briumvi) (CP.PHAR.621) (PDF)
- Ubrogepant (Ubrelvy) (CP.PHAR.476) (PDF)
- Ulcer Therapy Products (CP.PMN.277) (PDF)
- Umbralisib (Ukoniq) (CP.PHAR.531) (PDF)
- Unoprostone Isopropyl (Rescula) (HIM.PA.11) (PDF)
- Uridine triacetate (Vistogard) (HIM.PA.SP55) (PDF)
- Vadadustat (Vafseo) (CP.PHAR.677) (PDF)
- Valbenazine (Ingrezza, Ingrezza Sprinkle) (CP.PCH.48) (PDF)
- Valganciclovir (Valcyte) (CP.PCH.06) (PDF)
- Valoctocogene Roxaparvovec (Roctavian) (CP.PHAR.466) (PDF)
- Valrubicin (Valstar) (CP.PHAR.439) (PDF)
- Vamorolone (Agamree) (CP.PHAR.659) (PDF)
- Vandetanib (Caprelsa) (CP.PHAR.80) (PDF)
- Varenicline (Tyrvaya) (CP.PMN.273) (PDF)
- Velaglucerase alfa (VPRIV) (CP.PHAR.163) (PDF)
- Velmanase Alfa-tycv (Lamzede) (CP.PHAR.601) (PDF)
- Vemurafenib (Zelboraf) (CP.PHAR.91) (PDF)
- Venetoclax (Venclexta) (CP.PHAR.129) (PDF)
- Verteporfin (Visudyne) (CP.PHAR.187) (PDF)
- Vestronidase alfa-vjbk (Mepsevii) (CP.PHAR.374) (PDF)
- Vigabatrin (Sabril, Vigafyde) (CP.PHAR.169) (PDF)
- Vilazodone (Viibryd) (CP.PMN.145) (PDF)
- Viloxazine (Qelbree) (CP.PMN.264) (PDF)
- Viltolarsen (Viltepso) (CP.PHAR.484) (PDF)
- Vincristine Sulfate Liposome Injection (Marqibo) (CP.PHAR.315) (PDF)
- Vismodegib (Erivedge) (CP.PHAR.273) (PDF)
- Voclosporin (Lupkynis) (CP.PHAR.504) (PDF)
- Vorapaxar (Zontivity) (HIM.PA.146) (PDF)
- Voretigene Neparvovec-rzyl (Luxturna) (CP.PHAR.372) (PDF)
- Vorinostat (Zolinza) (CP.PHAR.83) (PDF)
- Vortioxetine (Trintellix) (CP.PMN.65) (PDF)
- Vosoritide (Voxzogo) (CP.PHAR.525) (PDF)
- Voxelotor (Oxbryta) (CP.PHAR.451) (PDF)
- Vutrisiran (Amvuttra) (CP.PHAR.550) (PDF)
- Zanubrutinib (Brukinsa) (CP.PHAR.467) (PDF)
- Zavegepant (Zavzpret) (CP.PHAR.630) (PDF)
- Zilucoplan (Zilbrysq) (CP.PHAR.616) (PDF)
- Ziv-aflibercept (Zaltrap) (CP.PHAR.325) (PDF)
- Zoledronic Acid (Reclast) (CP.PHAR.59) (PDF)
- Zuranolone (Zurzuvae) (CP.PHAR.650) (PDF)
- 340B Drug Payment Reduction (CC.PP.070) (PDF)
- Add on Code Billed Without Primary Code (CC.PP.030) (PDF)
- Acute Care Inpatient Hospital Claims - Sepsis Diagnosis (CC.PP.073) (PDF)
- Allergy Testing and Therapy (TX.CP.MP.100) (PDF)
- Assistant Surgeon (CC.PP.029) (PDF)
- Attention Deficit Hyperactivity Disorder Assessment and Treatment (CP.BH.124) (PDF)
- Bilateral Procedures (CC.PP.037) (PDF)
- Bronchial Thermoplasty (CP.MP.110) (PDF)
- Cardiac Biomarker Testing for Acute MI (CP.MP.156) (PDF)
- Cerumen Removal (CC.PP.008) (PDF)
- Clinical Validation of Modifier 25 (CC.PP.013) (PDF)
- Clinical Validation of Modifier 59 (CC.PP.014) (PDF)
- Code Editing Overview (TX.CC.PP.011) (PDF)
- Cosmetic Procedures (CC.PP.024) (PDF)
- Digital Analysis of EEGs (CP.MP.105) (PDF)
- Distinct Procedural Modifiers (CC.PP.020) (PDF)
- Drugs of Abuse: Presumptive Testing (CP.MP.208) (PDF)
- Duplicate Primary Code Billing (CC.PP.044) (PDF)
- E&M Bundling with Lab-Radiology (CC.PP.010) (PDF)
- E&M Medical Decision-Making (CC.PP.051) (PDF)
- Endometrial Ablation (EA) (CP.MP.106) (PDF)
- Enhanced Code Editing (TX.PP.011-A) (PDF)
- EpiFix Wound Treatment (CP.MP.140) (PDF)
- Evaluation and Management (E/M) Services Billed with Treatment Room Revenue Codes (CC.PP.071) (PDF)
- Evoked Potentials (CP.MP.134) (PDF)
- Genetic and Molecular Testing Services (TX.PP.551) (PDF)
- Genitourinary Lab Testing (TX.CP.MP.307) (PDF)
- Global Maternity Billing (CC.PP.016) (PDF)
- Holter Monitors (CP.MP.113) (PDF)
- Home Births (CP.MP.136) (PDF)
- Homocysteine Testing (CP.MP.121) (PDF)
- Hospital Visit Codes Billed with Labs (CC.PP.023) (PDF)
- Infectious Disease: Dermatologic Testing (TX.CP.MP.303) (PDF)
- Infectious Disease: Gastroenterologic Lab Testing (TX.CP.MP.304) (PDF)
- Infectious Disease: Multi-System Lab Testing (TX.CP.MP.302) (PDF)
- Infectious Disease: Respiratory Lab Testing (TX.CP.MP.301) (PDF)
- Infectious Disease: Vector-Borne and Tropical Diseases Lab Testing (TX.CP.MP.306) (PDF)
- Inpatient Only Procedures (CC.PP.018) (PDF)
- Intravenous Hydration (CC.PP.012) (PDF)
- Laser Skin Treatment (CP.MP.123) (PDF)
- Leveling of Emergency Room Services - Professional (CC.PP.053) (PDF)
- Leveling of Emergency Room Services - Facility (CC.PP.064)
- Low-frequency Ultrasound Debridement Noncontact Wound Therapy (CP.MP.139) (PDF)
- Maximum Units of Service (CC.PP.007) (PDF)
- Measure Serum 1,25 Vitamin D (CP.MP.152) (PDF)
- Mechanical Stretch Devices (CP.MP.144) (PDF)
- Moderate Conscious Sedation (CC.PP.015) (PDF)
- Modifier DOS Validation (CC.PP.034) (PDF)
- Modifier to Procedure Code Validation (CC.PP.028) (PDF)
- Multiple CPT Code Replacement (CC.PP.033) (PDF)
- Multiple Procedure Payment Reduction (MPPR) for Diagnostic Cardiovascular Procedures (CC.PP.065) (PDF)
- NCCI Unbundling (CC.PP.031) (PDF)
- Never Paid Events (CC.PP.017) (PDF)
- New Patient (CC.PP.036) (PDF)
- Non-obstetrical and Obstetrical Transabdominal and Transvaginal Ultrasounds (CC.PP.061) (PDF)
- Not Medically Necessary Inpatient Professional Services (CC.PP.060) (PDF)
- Outpatient Consultation (CC.PP.039) (PDF)
- Physician Visit Codes Billed with Labs (CC.PP.019) (PDF)
- Place of Service Mismatch (CC.PP.063) (PDF)
- Post-Operative Visits (CC.PP.042) (PDF)
- Pre-Operative Visits (CC.PP.041) (PDF)
- Primary Care and Preventive Lab Screening (TX.CP.MP.305) (PDF)
- Problem Oriented Visits Billed with Preventative Visits (CC.PP.057)
- Problem Oriented Visits Billed with Surgical Procedures (CC.PP.052)
- Professional Component Modifier (CC.PP.027) (PDF)
- Pulmonary Function Testing - CP.MP.242 (PDF)
- Pulse Oximetry with Office Visits (CC.PP.025) (PDF)
- Renal Hemodialysis (CC.PP.067) (PDF)
- Robotic Surgery (CC.PP.050) (PDF)
- Same Day Visits (CC.PP.040) (PDF)
- Sleep Studies Place of Services (CC.PP.035) (PDF)
- Status "B" Bundled Services (CC.PP.046) (PDF)
- Status "P" Bundled Services (CC.PP.049) (PDF)
- Supplies Billed on Same Day As Surgery (CC.PP.032) (PDF)
- Thyroid Testing in Pediatrics (CP.MP.154) (PDF)
- Transgender Related Services (CC.PP.047) (PDF)
- Ultrasound in Pregnancy (CP.MP.38) (PDF)
- Unbundled Professional Services (CC.PP.043) (PDF)
- Unbundled Surgical Procedures (CC.PP.045) (PDF)
- Unlisted Procedure Codes (CC.PP.009) (PDF)
- Urine Specimen Validity Testing (CC.PP.056) (PDF)
- Urodynamic Testing (CP.MP.98) (PDF)
- Vitamin D Testing in Children (CP.MP.157) (PDF)
- Wheelchair and Accessories (CC.PP.502) (PDF)
- Wireless Motility Capsule (CP.MP.143) (PDF)
Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS) and CHIP Policies
- ADHD Assessment and Treatment (CP.BH.124) (PDF)
- Allergy Testing and Therapy (TX.CP.MP.100) (PDF)
- Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (CP.MP.108) (PDF)
- Assistive Communication Device (TX.CP.MP.551) (PDF)
- Bariatric Surgery (CP.MP.37) (PDF)
- Bone-Anchored Hearing Aid (TX.CP.MP.522) (PDF)
- Caudal or Interlaminar Epidural Steroid Injections (CP.MP.164) (PDF)
- Child and Adolescent Strength and Needs (CANS) 2.0 Medical Necessity Criteria (TX.CP.MP.543) (PDF)
- Cochlear Implant Replacements (CP.MP.14) (PDF)
- Cognitive Rehabilitation Therapy (TX.CP.MP.553) (PDF)
- Cosmetic and Reconstructive Procedures (CP.MP.31) (PDF)
- Custom Mobility Seating and Systems (TX.CP.MP.599) (PDF)
- Dental Therapy Under General Anesthesia (TX.CP.MP.518) (PDF)
- Diabetic Supplies (TX.CP.MP.526) (PDF)
- Diaphragmatic/Phrenic Nerve Stimulation (CP.MP.203) (PDF)
- Donor Lymphocyte Infusion (CP.MP.101) (PDF)
- Durable Medical Equipment and Orthotics and Prosthetics Guidelines (CP.MP.107) (PDF)
- Durable Medical Equipment and Medical Supplies (TX.CP.MP.552) (PDF)
- EEG in the Evaluation of Headache (CP.MP.155) (PDF)
- Elective Deliveries Before 39 Weeks Gestational Age (TX.CP.MP.513) (PDF)
- Electric Tumor Treating Fields (Optune) (CP.MP.145) (PDF)
- Enteral Nutrition and Supplies (TX.CP.MP.550) (PDF)
- Excision of Lesions (TX.CP.MP.525) (PDF)
- Experimental Technologies (CP.MP.36) - for CHIP only (PDF)
- Facet Joint Interventions (CP.MP.171) (PDF)
- Fecal Incontinence Treatments (CP.MP.137) (PDF)
- Fetal Surgery In Utero for Prenatally Diagnosed Malformations (CP.MP.129) (PDF)
- Gastric Electrical Stimulation (CP.MP.40) (PDF)
- Heart-Lung Transplant (CP.MP.132) (PDF)
- Hyperhidrosis Treatments (CP.MP.62) (PDF)
- Implantable Intrathecal or Epidural Pain Pump (CP.MP.173) (PDF)
- Implantable Wireless Pulmonary Artery Pressure Monitoring (CP.MP.160) (PDF)
- Therapeutic Utilization of Inhaled Nitric Oxide (CP.MP.87) (PDF)
- Intestinal and Multivisceral Transplant (CP.MP.58) (PDF)
- Lung Transplantation (CP.MP.57) (PDF)
- Mastectomy for Pubertal Gynecomastia (TX.CP.MP.571) (PDF)
- Mechanical Stretch Devices (CP.MP.144) (PDF)
- Medical Necessity Criteria (TX.CP.MP.500) (PDF)
- Neonatal Abstinence Syndrome Guidelines (CP.MP.86) (PDF)
- Neonatal Sepsis Management (CP.MP.85) (PDF)
- Nerve Blocks and Neurolysis for Pain Management (CP.MP.170) (PDF)
- NICU Apnea Bradycardia Guidelines (CP.MP.82) (PDF)
- NICU Discharge Guidelines (CP.MP.81) (PDF)
- Non-Emergent Ambulance Transportation (TX.CP.MP.507) (PDF)
- Non-Myeloablative Allogeneic Stem Cell Transplants (CP.MP.141) (PDF)
- Obstetrical Home Care Programs (CP.MP.91) (PDF)
- Orthognathic Surgery (CP.MP.202) (PDF)
- Osteogenic Stimulation (CP.MP.194)
- Oxygen Use and Concentrators (CP.MP.190) - for CHIP only (PDF)
- Pancreas Transplatation (CP.MP.102) (PDF)
- Panniculectomy (CP.MP.109) (PDF)
- Pediatric Heart Transplant (CP.MP.138) (PDF)
- Pediatric Kidney Transplant (CP.MP.246) (PDF)
- Pediatric Liver Transplant (CP.MP.120) (PDF)
- Phototherapy for Neonatal Hyperbilirubinemia (CP.MP.150) (PDF)
- Physical, Occupational and Speech Therapy Services (TX.CP.MP.549) (PDF)
- Private Duty Nursing (TX.CP.MP.520) (PDF)
- Private Duty Nursing - for CHIP only (TX.CP.MP.521) (PDF)
- Reduction mammoplasty & Gynecomastia Surgery (CP.MP.51) (PDF)
- Sacroiliac Joint Interventions for Pain Management (CP.MP.166) (PDF)
- Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (CP.MP.146) (PDF)
- Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (CP.MP.165) (PDF)
- Short Inpatient Hospital Stay (TX.CP.MP.582) (PDF)
- Skilled Nursing Visits (TX.CP.MP.538) (PDF)
- Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (CP.MP.117) (PDF)
- Tandem Transplant (CP.MP.162) (PDF)
- Total Artificial Heart (CP.MP.127) (PDF)
- Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (CP.MP.163) - for CHIP only (PDF)
- Transplant Service Documentation Requirements (CP.MP.247) (PDF)
- Urinary Incontinence Devices and Treatments (CP.MP.142) (PDF)
- Vagus Nerve Stimulation (CP.MP.12) (PDF)
- Ventricular Assist Devices (CP.MP.46) (PDF)
Please note:
- The policies listed below are used for medically billed drugs only. Also, the date in the link name is either the most recent revision date, or the effective date of the policy if no clinically significant changes have been made since September 1, 2019. Please refer to change log for the original effective date and previous revisions to the policy.
- Consistent with guidance issued by Texas Medicaid for Clinician Administered Drugs (CAD) and the regulation at 42 CFR §438.210 and 42 CFR §457.1230(d), Superior HealthPlan does not use any standard for determining medical necessity that is more restrictive than what is developed by the Vendor Drug Program. For more details on the clinical policy and prior authorization requirements, please review the Outpatient Drug Services Handbook located at: https://www.tmhp.com/resources/provider-manuals/tmppm.
Superior routinely reviews the Texas Medicaid Provider Procedures Manual (TMPPM) to ensure any of our clinical policies for medical necessity are not more restrictive than what is provided for fee-for-service with regards to amount, duration and scope of service. TMPPM is regularly updated to reflect the most recent policy and procedure changes. Advanced notification of upcoming changes appear as banner messages located at the TMHP Banner Messages.
- Abaloparatide (Tymlos) (CP.PHAR.345) (PDF)
- AbobotulinumtoxinA (Dysport) (CP.PHAR.230) (PDF)
- Adalimumab (Humira), Adalimumab-afzb (Abrilada), Adalimumab-atto (Amjevita), Adalimumab-adbm (Cyltezo), Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio), Adalimumab-adaz (Hyrimoz), Adalimumab-aacf (Idacio), Adalimumab-ryvk (Simlandi), Adalimumab-aaty (Yuflyma), Adalimumab-aqvh (Yusimry) (CP.PHAR.242) (PDF)
- Ado-Trastuzumab Emtansine (Kadcyla) (CP.PHAR.229) (PDF)
- Aducanumab-avwa (Aduhelm) (TX.CC.PHAR.18) (PDF)
- Afamelanotide (Scenesse) (CP.PHAR.444) (PDF)
- Aflibercept (Eylea, Eylea HD), Aflibercept-yszy (Opuviz), Aflibercept-jbvf (Yesafili), Aflibercept-mrbb (Ahzantive), Aflibercept-abzv (Enzeevu), Aflibercept-ayyh (Pavblu) (PDF)
- Alemtuzumab (Lemtrada) (CP.PHAR.243) (PDF)
- Alirocumab (Praluent) (CP.PHAR.124) (PDF)
- Allogeneic cultured keratinocytes and dermal fibroblasts (StrataGraft) (CP.PHAR.562) (PDF)
- Allogenic processed thymus tissue-agdc (Rethymic) (CP.PHAR.563) (PDF)
- Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (CP.PHAR.94) - (PDF)
- Amikacin (Arikayce) (CP.PHAR.401) (PDF)
- Amisulpride (Barhemsys) (CP.PMN.236) (PDF)
- Amivantamab-vmjw (Rybrevant) (CP.PHAR.544) (PDF)
- Anakinra (Kineret) (CP.PHAR.244) (PDF)
- Anti-Inhibitor Coagulant Complex, Human (Feiba) (CP.PHAR.217) (PDF)
- Antithrombin III (ATryn, Thrombate III) (CP.PHAR.564) (PDF)
- Antithymocyte Globulin (Atgam, Thymoglobulin) (CP.PHAR.506) (PDF)
- Apomorphine (Apokyn) (CP.PHAR.488) (PDF)
- Aprepitant (Aponvie, Emend, Cinvanti), Fosaprepitant (Emend for injection, Focinvez) (CP.PMN.19) (PDF)
- Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) (CP.PHAR.290) (PDF)
- Asfotase Alfa (Strensiq) (CP.PHAR.328) (PDF)
- Atezolizumab (Tecentriq) (CP.PHAR.235) (PDF)
- Atidarsagene autotemcel (Lenmeldy) (CP.PHAR.602) (PDF)
- Avacincaptad pegol (Izervay) (CP.PHAR.641) (PDF)
- Avelumab (Bavencio) (CP.PHAR.333) (PDF)
- Axicabtagene Ciloleucel (Yescarta®) (TX.CC.PHAR.03) (PDF)
- Azacitidine (Onureg, Vidaza) (CP.PHAR.387) (PDF)
- Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (CP.PHAR.149) (PDF)
- Belantamab Mafodotin-blmf (Blenrep) (CP.PHAR.469) (PDF)
- Belatacept (Nulojix) (CP.PHAR.201) (PDF)
- Belinostat (Beleodaq) (CP.PHAR.311) (PDF)
- Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (CP.PHAR.307)(PDF)
- Benralizumab (Fasenra) (TX.CC.PHAR.17) (PDF)
- Beremagene geperpavec-svdt (Vyjuvek) (TX.CC.PHAR.30) (PDF)
- Betibeglogene autotemcel (Zynteglo) (TX.CC.PHAR.24) (PDF)
- Bevacizumab (Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev) (CP.PHAR.93) (PDF)
- Bezlotoxumab (Zinplava) (CP.PHAR.300) (PDF)
- Bimatoprost Implant (Durysta) (CP.PHAR.486) (PDF)
- Bimekizumab-bkzx (Bimzelx) (CP.PHAR.660) (PDF)
- Blinatumomab (Blincyto) (CP.PHAR.312) (PDF)
- Bortezomib (Velcade) (CP.PHAR.410) (PDF)
- Brentuximab Vedotin (Adcetris) (CP.PHAR.303) (PDF)
- Brexucabtagene autoleucel (Tecartus) (TX.CC.PHAR.21) (PDF)
- Brodalumab (Siliq) (CP.PHAR.375) (PDF)
- Brolucizumab (Beovu) (CP.PHAR.445) (PDF)
- Buprenorphine Injection (Sublocade, Brixadi) (CP.PHAR.289) (PDF)
- Burosumab-Twza (Crysvita) (TX.CC.PHAR.05) (PDF)
- C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (CP.PHAR.202) (PDF)
- Cabazitaxel (Jevtana) (CP.PHAR.316) (PDF)
- Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (CP.PHAR.573) (PDF)
- Casimersen (Amondys 45) (TX.CC.PHAR.11) (PDF)
- Canakinumab (Ilaris) (CP.PHAR.246) (PDF)
- Caplacizumab-yhdp (Cablivi) (CP.PHAR.416) (PDF)
- Carfilzomib (Kyprolis) (CP.PHAR.309) (PDF)
- Cemiplimab-rwlc (Libtayo) (CP.PHAR.397) (PDF)
- Cenegermin-bkbj (Oxervate) (CP.PMN.186) (PDF)
- Cerliponase alfa (Brineura) (TX.CC.PHAR.19) (PDF)
- Certolizumab (Cimzia) (CP.PHAR.247) (PDF)
- Cetuximab (Erbitux) (CP.PHAR.317) (PDF)
- Chloramphenicol Sodium Succinate (CP.PHAR.388) (PDF)
- Ciltacabtagene autoleucel (Carvykti) (TX.CC.PHAR.22) (PDF)
- Cipaglucosidase alfa-atga (Pombiliti) (TX.CC.PHAR.41) (PDF)
- Collagenase Clostridium Histolyticum (Xiaflex) (CP.PHAR.82) (PDF)
- Copanlisib (Aliqopa) (CP.PHAR.357) (PDF)
- Corticosteroids for Ophthalmic Injection (Dextenza, Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (CP.PHAR.385) (PDF)
- Cosyntropin (Cortrosyn) (CP.PHAR.203) (PDF)
- Crovalimab (PiaSky) (CP.PHAR.664) (PDF)
- Cyclosporine (Cequa, Restasis, Verkazia, Vevye) (CP.PMN.48) (PDF)
- Cytomegalovirus Immune Globulin (Cytogam) (CP.PHAR.277) (PDF)
- Dalteparin (Fragmin) (CP.PHAR.225) (PDF)
- Daptomycin (Cubicin, Cubicin RF, Dapzura RT) (CP.PHAR.351) (PDF)
- Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (CP.PHAR.310) (PDF)
- Darbepoetin Alfa (Aranesp) (CP.PHAR.236) (PDF)
- Daunorubicin-cytarabine (Vyxeos) (CP.PHAR.352) (PDF)
- DaxibotulinumtoxinA-lanm (Daxxify) (CP.PHAR.651) (PDF)
- Deferoxamine (Desferal) (CP.PHAR.146) (PDF)
- Degarelix Acetate (Firmagon) (TX.CC.PHAR.34) (PDF)
- Delafloxacin (Baxdela) (CP.PMN.115) (PDF)
- Delandistrogene moxeparvovec-rokl (Elevidys) (TX.CC.PHAR.32) (PDF)
- Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (CP.PHAR.58) (PDF)
- Desmopressin Acetate (DDAVP, Stimate, Nocdurna) (CP.PHAR.214) (CP.PHAR.214) (PDF)
- Dexrazoxane (Totect) (CP.PHAR.418) (PDF)
- Dornase Alfa (Pulmozyme) (CP.PHAR.212) (PDF)
- Dostarlimab-gxly (Jemperli) (CP.PHAR.540) (PDF)
- Dupilumab (Dupixent) (CP.PHAR.336) (PDF)
- Durvalumab (Imfinzi) (CP.PHAR.339) (PDF)
- Ecallantide (Kalbitor) (CP.PHAR.177) (PDF)
- Eculizumab (Soliris), Eculizumab-aeeb (Bkemv), Eculizumab-aagh (Epysqli) (CP.PHAR.97) (PDF)
- Edaravone (Radicava, Radivaca ORS) (CP.PHAR.343) (PDF)
- Efgartigimod Alfa-fcab, Efgartigimod/Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (CP.PHAR.555) (PDF)
- Elapegademase-lvlr (Revcovi) (CP.PHAR.419) (PDF)
- Elivaldogene autotemcel (Skysona) (TX.CC.PHAR.25) (PDF)
- Elotuzumab (Empliciti) (CP.PHAR.308) (PDF)
- Elranatamab-bcmm (Elrexfio) (CP.PHAR.652) (PDF)
- Emicizumab-kxwh (Hemlibra) (CP.PHAR.370) (PDF)
- Enfortumab Vedotin-ejfv (Padcev) (CP.PHAR.455) (PDF)
- Enfuvirtide (Fuzeon) (CP.PHAR.41) (PDF)
- Enoxaparin (Lovenox) (CP.PHAR.224) (PDF)
- Enzyme Replacement Therapy(Fabrazyme, Lumizyme, Nexviazyme, Vimizim, Naglazyme,Elaprase, Cerezyme, Aldurazyme, Ceprotin, Kanuma, Elelyso,VPRIV, Xenpozyme, Elfabrio, Adzynma) (TX.CC.PHAR.33) (PDF)
- Epcoritamab-bysp (Epkinly) (CP.PHAR.634) (PDF)
- Eplontersen (Wainua) (CP.PHAR.633) (PDF)
- Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (CP.PHAR.237) (PDF)
- Epoprostenol (Flolan, Veletri) (CP.PHAR.192) (PDF)
- Eptinezumab (Vyepti) (CP.PHAR.489) (PDF)
- Eribulin Mesylate (Halaven) (CP.PHAR.318) (PDF)
- Erenumab-aaoe (Aimovig) (CP.PHAR.128) (PDF)
- Erwinia Asparaginase (Rylaze) (CP.PHAR.301) (PDF)
- Etanercept (Enbrel) (CP.PHAR.250) (PDF)
- Etelcalcetide (Parsabiv) (CP.PHAR.379) (PDF)
- Eteplirsen (Exondys51) (TX.CC.PHAR.06) (PDF)
- Etranacogene dezaparvovec-drlb (Hemgenix) (TX.CC.PHAR.26) (PDF)
- Evinacumab-dgnb (Evkeeza) (CP.PHAR.511) (PDF)
- Evolocumab (Repatha) (CP.PHAR.123) (PDF)
- Exagamglogene autotemcel (Casgevy) (CP.PHAR.603) (PDF)
- Factor IX (Human, Recombinant) (CP.PHAR.218) (PDF)
- Factor IX Complex, Human (Profilnine) (CP.PHAR.219) (PDF)
- Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (CP.PHAR.220) (PDF)
- Factor VIII (Human, Recombinant) (CP.PHAR.215) (PDF)
- Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (CP.PHAR.216) (PDF)
- Factor XIIIa_Recombinant (Tretten) (CP.PHAR.222) (PDF)
- Factor XIII Human (Corifact) (CP.PHAR.221) (PDF)
- Fam-trastuzumab Deruxtecan-nxki (Enhertu) (CP.PHAR.456) (PDF)
- Faricimab-svoa (Vabysmo) (CP.PHAR.581) (PDF)
- Fecal microbiota, live-jslm (Rebyota) (CP.PHAR.613) (PDF)
- Ferric Carboxymaltose (Injectafer) (CP.PHAR.234) (PDF)
- Ferric Derisomaltose (Monoferric) (CP.PHAR.480) (PDF)
- Ferric Pyrophosphate (Triferic, Triferic Avnu) (CP.PHAR.624) (PDF)
- Ferumoxytol (Feraheme) (CP.PHAR.165) (PDF)
- Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (CP.PHAR.526) (PDF)
- Fidanacogene Elaparvovec-dzkt (Beqvez) (CP.PHAR.643) (PDF)
- Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix), Filgrastim-aafi (Nivestym), Filgrastim-ayow (Releuko), Filgrastim-txid (Nypozi) (CP.PHAR.297) (PDF)
- Fondaparinux (Arixtra) (CP.PHAR.226) (PDF)
- Fosdenopterin (Nulibry) (CP.PHAR.471) (PDF)
- Fremanezumab-vfrm (Ajovy) (CP.PHAR.403) (PDF)
- Fulvestrant (Faslodex Injection) (CP.PHAR.424) (PDF)
- Furosemide (Furoscix) (CP.PHAR.608) (PDF)
- Galcanezumab-gnlm (Emgality) (CP.PHAR.404) (PDF)
- Gemtuzumab Ozogamicin (Mylotarg) (CP.PHAR.358) (PDF)
- Givosiran (Givlaari) (CP.PHAR.457) (PDF)
- Glatiramer Acetate (Copaxone, Glatopa) (CP.PHAR.252) (PDF)
- Glaucoma Agents (Iyuzeh, Omlonti, Rhopressa, Rocklatan, Vyzulta) (CP.PMN.286) (PDF)
- Glofitamab-gxbm (Columvi) (CP.PHAR.636) (PDF)
- Golimumab (Simponi, Simponi Aria) (CP.PHAR.253) (PDF)
- Golodirsen (Vyondys53) (TX.CC.PHAR.09) (PDF)
- Granisetron (Sancuso, Sustol) (CP.PMN.74) (PDF)
- Guselkumab (Tremfya) (CP.PHAR.364) (PDF)
- Hemin (panhematin) (CP.PHAR.181) (PDF)
- Histrelin Acetate (Vantas, Supprelin LA) (TX.CC.PHAR.37) (PDF)
- Hormonal therapy agents (TX.CC.PHAR.39) (PDF)
- Human Growth Hormone (Somapacitan, Somatrogon, Somatropin, Lonapegsomatropin-tcgd) (CP.PHAR.517) (PDF)
- Ibandronate Injection (Boniva) (CP.PHAR.189) (PDF)
- Icatibant (Firazyr) (CP.PHAR.178) (PDF)
- Idecabtagene Vicleucel (Abecma) (TX.CC.PHAR.12) (PDF)
- Iloprost (Ventavis) (CP.PHAR.193) (PDF)
- Immune Globulins (CP.PHAR.103) (PDF)
- Inclisiran (Leqvio) (CP.PHAR.568) (PDF)
- IncobotulinumtoxinA (Xeomin) (CP.PHAR.231) (PDF)
- Infertility and Fertility Preservation (CP.PHAR.131) (PDF)
- Infliximab (Avsola, Inflectra, Remicade, Renflexis, Zymfentra) (CP.PHAR.254) (PDF)
- Inotersen (Tegsedi) (CP.PHAR.405) (PDF)
- Inotuzumab ozogamicin (Besponsa) (TX.CC.PHAR.02) (PDF)
- Interferon Beta-1a (Avonex, Rebif) (CP.PHAR.255) (PDF)
- Interferon Beta-1b (Betaseron, Extavia) (CP.PHAR.256) (PDF)
- Interferon Gamma- 1b (Actimmune) (CP.PHAR.52) (PDF)
- Iobenguane I 131 (Azedra) (CP.PHAR.459) (PDF)
- Ipilimumab (Yervoy) (CP.PHAR.319) (PDF)
- Irinotecan Liposome (Onivyde) (CP.PHAR.304) (PDF)
- Isatuximab-irfc (Sarclisa) (CP.PHAR.482) (PDF)
- Isavuconazonium (Cresemba) (CP.PMN.154) (PDF)
- Ixekizumab (Taltz) (CP.PHAR.257) (PDF)
- Ketamine (Ketalar) (CP.PMN.296) (PDF)
- Lacosamide (Motpoly XR, Vimpat) (CP.PMN.155) (PDF)
- Lanadelumab-fylo (Takhzyro) (CP.PHAR.396) (PDF)
- Lanreotide (Somatuline Depot and Unbranded) (CP.PHAR.391) (PDF)
- Lecanemab-irmb (Leqembi) (TX.CC.PHAR.27) (PDF)
- Lefamulin (Xenleta) (CP.PMN.219) (PDF)
- Lenacapavir (Sunlenca) (CP.PHAR.622) (PDF)
- Letermovir (Prevymis) (CP.PHAR.367) (PDF)
- Leucovorin Injection (CP.PHAR.393) (PDF)
- Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (TX.CC.PHAR.35)
- Levoleucovorin (Fusilev, Khapzory) (CP.PHAR.151) (PDF)
- Lifileucel (Amtagvi) (CP.PHAR.598) (PDF)
- Lisocabtagene maraleucel (Breyanzi) (TX.CC.PHAR.13) (PDF)
- Linezolid (Zyvox) (CP.PMN.27) (PDF)
- Loncastuximab tesirine-lpyl (Zynlonta) (CP.PHAR.539) (PDF)
- Lovotibeglogene Autotemcel (Lyfgenia) (CP.PHAR.627) (PDF)
- Lumasiran (Oxlumo) (CP.PHAR.473) (PDF)
- Lurbinectedin (Zepzelca) (CP.PHAR.500) (PDF)
- Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (CP.PHAR.582) (PDF)
- Lutetium Lu 177 dotatate (Lutathera) (CP.PHAR.384) (PDF)
- Margetuximab-cmkb (Margenza) (CP.PHAR.522) (PDF)
- Melphalan flufenamide (Pepaxto) (CP.PHAR.535) (PDF)
- Melphalan (Hepzato) (CP.PHAR.653) (PDF)
- Mepolizumab (Nucala) (TX.CC.PHAR.14) (PDF)
- Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo) (CP.PHAR.134) (PDF)
- Methoxy polyethylene glycol-epoetin beta (Mircera) (CP.PHAR.238) (PDF)
- Methylnaltrexone Bromide (Relistor) (CP.PMN.169) (PDF)
- Metreleptin (Myalept) (CP.PHAR.425) (PDF)
- Mirikizumab-mrkz (Omvoh) (CP.PHAR.662) (PDF)
- Mirvetuximab soravtansine-gynx (Elahere) (CP.PHAR.617) (PDF)
- Mitomycin for Pyelocalyceal Solution (Jelmyto) (CP.PHAR.495) (PDF)
- Mitoxantrone (CP.PHAR.258) (PDF)
- Mometasone Furoate (Sinuva) (CP.PHAR.448) (PDF)
- Mosunetuzumab-axgb (Lunsumio) (CP.PHAR.618) (PDF)
- Motixafortide (Aphexda) (CP.PHAR.655) (PDF)
- Nadofaragene firadenovec-vncg (Adstiladrin) (TX.CC.PHAR.31) (PDF)
- Naloxone (Evzio) (CP.PMN.139) (PDF)
- Naltrexone (Vivitrol) (CP.PHAR.96) (PDF)
- Natalizumab (Tysabri), Natalizumab-sztn (Tyruko) (CP.PHAR.259) (PDF)
- Naxitamab-gqgk (Danyelza) (CP.PHAR.523) (PDF)
- Necitumumab (Portrazza) (CP.PHAR.320) (PDF)
- Nedosiran (Rivfloza) (CP.PHAR.619) (PDF)
- Netupitant and Palonosetron (Akynzeo), Fosnetupitant and Palonosetron (Akynzeo IV) (CP.PMN.158) (PDF)
- Nivolumab (Opdivo) (CP.PHAR.121) (PDF)
- Nivolumab and Relatlimab-rmbw (Opdualag) (CP.PHAR.588) (PDF)
- No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (CP.PMN.255) (PDF)
- Nogapendekin alfa inbakicept-pmln (Anktiva) (TX.CC.PHAR.42) (PDF)
- Nusinersen (Spinraza) (TX.CC.PHAR.01) (PDF)
- Obinutuzumab (Gazyva) (CP.PHAR.305) (PDF)
- Ocrelizumab (Ocrevus) (CP.PHAR.335) (PDF)
- Octreotide Acetate (Sandostatin, Sandostatin LAR, Mycapssa) (CP.PHAR.40) (PDF)
- Ofatumumab (Arzerra, Kesimpta) (CP.PHAR.306) (PDF)
- Off-Label Use (CP.PMN.53)(PDF)
- Olanzapine Long-Acting Injection (Zyprexa Relprevv) (CP.PHAR.292) (PDF)
- Omacetaxine (Synribo) (CP.PHAR.108) (PDF)
- Omadacycline (Nuzyra) (CP.PMN.188) (PDF)
- Omalizumab (Xolair) (TX.CC.PHAR.15) (PDF)
- OnabotulinumtoxinA (Botox) (CP.PHAR.232) (PDF)
- Onasemnogene Abeparvovec-xioi (Zolgensma) (TX.CC.PHAR.08) (PDF)
- Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (CP.PHAR.536) (PDF)
- Paclitaxel protein-bound (Abraxane) (CP.PHAR.176) (PDF)
- Paliperidone Long-Acting Injections (Invega Hafyera, Invega Sustenna, Invega Trinza) (CP.PHAR.291) (PDF)
- Panitumumab (Vectibix) (CP.PHAR.321) (PDF)
- Parathyroid Hormone (Natpara) (CP.PHAR.282) (PDF)
- Paricalcitol Injection (Zemplar) (CP.PHAR.270) (PDF)
- Pasireotide (Signifor, Signifor LAR) (CP.PHAR.332) (PDF)
- Pegcetacoplan (Empaveli, Syfovre) (CP.PHAR.524) (PDF)
- Pegaspargase (Oncaspar), Calaspargase pegol-mknl (Asparlas) (CP.PHAR.353) (PDF)
- Pegfilgrastim (Neulasta, Neulasta Onpro), Pegfilgrastimjmdb(Fulphila), Pegfilgrastim-pbbk (Fylnetra), Pegfilgrastim-apgf(Nyvepria), Eflapegrastim-xnst (Rolvedon), Efbemalenograstim alfa-vuxw(Ryzneuta), Pegfilgrastim-fpgk (Stimufend), Pegfilgrastim-cbqv (Udenyca,Udenyca Autoinjector, Udenyca Onbody), Pegfilgrastim-bmez (Ziextenzo) (CP.PHAR.296) (PDF)
- Peginterferon Alfa-2a (Pegasys) (CP.PHAR.89) (PDF)
- Peginterferon Beta-1a (Plegridy) (CP.PHAR.271) (PDF)
- Pegloticase (Krystexxa) (CP.PHAR.115) (PDF)
- Pegunigalsidase alfa-iwxj (Elfabrio) (CP.PHAR.512) (PDF)
- Pegvisomant (Somavert) (CP.PHAR.389) (PDF)
- Pembrolizumab (Keytruda) (CP.PHAR.322) (PDF)
- Pemetrexed (Alimta, Pemfexy) (CP.PHAR.368) (PDF)
- Pertuzumab (Perjeta) (CP.PHAR.227) (PDF)
- Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (CP.PHAR.501) (PDF)
- Plasminogen, human-tvmh (Ryplazim) (CP.PHAR.513) (PDF)
- Plerixafor (Mozobil) (CP.PHAR.323) (PDF)
- Polatuzumab Vedotin-piiq (Polivy) (CP.PHAR.433) (PDF)
- Pozelimab-bbfg (Veopoz) (CP.PHAR.626) (PDF)
- Pralatrexate (Folotyn) (CP.PHAR.313) (PDF)
- Pramlintide (Symlin) (CP.PMN.129)(PDF)
- Ramucirumab (Cyramza) (CP.PHAR.119) (PDF)
- Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) (CP.PHAR.186) (PDF)
- Ravulizumab-cwvz (Ultomiris) (CP.PHAR.415) (PDF)
- Repository Corticotropin Injection (Acthar Gel, Purified Cortrophin Gel) (CP.PHAR.168) (PDF)
- Reslizumab (Cinqair) (TX.CC.PHAR.16) (PDF)
- Retifanlimab-dlwr (Zynyz) (CP.PHAR.629) (PDF)
- Rilonacept (Arcalyst) (CP.PHAR.266) (PDF)
- RimabotulinumtoxinB (Myobloc) (CP.PHAR.233) (PDF)
- Risankizumab-rzaa (Skyrizi) (CP.PHAR.426) (PDF)
- Risperidone Long-Acting Injection (Perseris, Risperdal Consta, Rykindo, Uzedy) (CP.PHAR.293) (PDF)
- Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (CP.PHAR.260)(PDF)
- Rolapitant (Varubi) (CP.PMN.102) (PDF)
- Romidepsin (Istodax) (CP.PHAR.314)(PDF)
- Romiplostim (Nplate) (CP.PHAR.179) (PDF)
- Romosozumab-aqqg (Evenity) (CP.PHAR.428) (PDF)
- Ropeginterferon alfa-2b-njft (Besremi) (CP.PHAR.570) (PDF)
- Rozanolixizumab-noli (Rystiggo) (CP.PHAR.648) (PDF)
- Sacituzumab govitecan-hziy (Trodelvy) (CP.PHAR.475) (PDF)
- Sargramostim (Leukine) (CP.PHAR.295) (PDF)
- Sarilumab (Kevzara) (CP.PHAR.346) (PDF)
- Satralizumab-mwge (Enspryng) (CP.PHAR.463) (PDF)
- Secukinumab (Cosentyx) (CP.PHAR.261) (PDF)
- Selexipag (Uptravi) (CP.PHAR.196) (PDF)
- Setmelanotide (Imcivree) (CP.PHAR.491) (PDF)
- Sildenafil (Revatio, Liqrev) (CP.PHAR.197) (PDF)
- Siltuximab (Sylvant) (CP.PHAR.329) (PDF)
- Sipuleucel-T (Provenge) (CP.PHAR.120) (PDF)
- Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (CP.PHAR.574) (PDF)
- Sodium thiosulfate (Pedmark) (CP.PHAR.610) (PDF)
- Sotatercept (Winrevair) (CP.PHAR.657) (PDF)
- Spesolimab-sbzo (Spevigo) (CP.PHAR.606) (PDF)
- Sutimlimab-jome (Enjaymo) (CP.PHAR.503) (PDF)
- Tafasitamab-cxix (Monjuvi) (CP.PHAR.508) (PDF)
- Talimogene laherepvec (Imlygic) (CP.PHAR.542) (PDF)
- Talquetamab-tgvs (Talvey) (CP.PHAR.649) (PDF)
- Tarlatamab-dlle (Imdelltra) (TX.CC.PHAR.43) (PDF)
- Tebentafusp-tebn (Kimmtrak) (CP.PHAR.575) (PDF)
- Teclistamab-cqyv (Tecvayli) (CP.PHAR.611) (PDF)
- Tedizolid (Sivextro) (CP.PMN.62) (PDF)
- Teduglutide (Gattex) (CP.PHAR.114) (PDF)
- Temozolomide (Temodar) (CP.PHAR.77) (PDF)
- Temsirolimus (Torisel) (CP.PHAR.324) (PDF)
- Teplizumab-mzwv (Tzield) (TX.CC.PHAR.23) (PDF)
- Teriparatide (Forteo, Bonsity) (CP.PHAR.188) (PDF)
- Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (TX.CC.PHAR.38) (PDF)
- Tezepelumab-ekko (Tezspire) (TX.CC.PHAR.20) (PDF)
- Thyrotropin alfa (Thyrogen) (CP.PHAR.95) (PDF)
- Tildrakizumab-asmn (Ilumya) (CP.PHAR.386) (PDF)
- Tisagenlecleucel (Kymriah) (TX.CC.PHAR.07) (PDF)
- Tislelizumab-jsgr (Tevimbra) (CP.PHAR.687) (PDF)
- Tisotumab vedotin-tftv (Tivdak) (CP.PHAR.561) (PDF)
- Tocilizumab (Actemra), Tocilizumab-bavi (Tofidence), Tocilizumab-aazg (Tyenne) (CP.PHAR.263) (PDF)
- Tofersen (Qalsody) (TX.CC.PHAR.28) (PDF)
- Topotecan (Hycamtin) (CP.PHAR.64) (PDF)
- Toripalimab (Loqtorzi) (CP.PHAR.668) (PDF)
- Trabectedin (Yondelis) (CP.PHAR.204) (PDF)
- Tralokinumab-ldrm (Adbry) (CP.PHAR.577) (PDF)
- Trastuzumab Biosimilars Trastuzumab-Hyaluronidase (CP.PHAR.228) (PDF)
- Travoprost (iDose TR) (CP.PHAR.672) (PDF)
- Tremelimumab-actl (Imjudo) (CP.PHAR.612) (PDF)
- Treprostinil (Orenitram, Remodulin, Tyvaso) (CP.PHAR.199) (PDF)
- Triamcinolone ER Injection (Zilretta) (CP.PHAR.371) (PDF)
- Triptorelin Pamoate (Trelstar, Triptodur) (TX.CC.PHAR.36) (PDF)
- Ublituximab-xiiy (Briumvi) (CP.PHAR.621) (PDF)
- Ustekinumab (Stelara), Ustekinumab-ttwe (Pyzchiva), Ustekinumab-aekn (Selarsdi), Ustekinumab-auub (Wezlana) (CP.PHAR.264) (PDF)
- Valoctocogene roxaparvovec-rvox (Roctavian) (TX.CC.PHAR.29) (PDF)
- Valrubicin (Valstar) (CP.PHAR.439) (PDF)
- Vedolizumab (Entyvio) (CP.PHAR.265) (PDF)
- Velmanase alfa-tycv (Lamzede) (TX.CC.PHAR.40) (PDF)
- Verteporfin (Visudyne) (CP.PHAR.187) (PDF)
- Viltolarsen (Viltepso) (TX.CC.PHAR.10) (PDF)
- Vincristine Sulfate Liposome Injection (Marqibo) (CP.PHAR.315) (PDF)
- Voretigene neparvovec-rzyl (Luxturna®) Criteria (TX.CC.PHAR.04) (PDF)
- Vosoritide (Voxzogo) (CP.PHAR.525) (PDF)
- Zilucoplan (Zilbrysq) (CP.PHAR.616) (PDF)
- Ziv-aflibercept (Zaltrap) (CP.PHAR.325) (PDF)
- Zoledronic Acid (Reclast) (CP.PHAR.59) (PDF)
- 30 Day Readmission (CC.PP.501) (PDF)
- Add on Code Billed Without Primary Code (CC.PP.030) (PDF)
- Acute Care Inpatient Hospital Claims - Sepsis Diagnosis (CC.PP.073) (PDF)
- Allergy Testing and Therapy (TX.CP.MP.100) (PDF)
- Assistant Surgeon (CC.PP.029) (PDF)
- Attention Deficit Hyperactivity Disorder Assessment and Treatment (CP.BH.124) (PDF)
- Bilateral Procedures (CC.PP.037) (PDF)
- Bronchial Thermoplasty (CP.MP.110) (PDF)
- Cardiac Biomarker Testing for Acute MI (CP.MP.156) (PDF)
- Cerumen Removal (CC.PP.008) (PDF)
- Clinical Validation of Modifier 25 (CC.PP.013) (PDF)
- Clinical Validation of Modifier 59 (CC.PP.014) (PDF)
- Code Editing Overview (TX.CC.PP.011) (PDF)
- Cosmetic Procedures (CC.PP.024) (PDF)
- Digital EEG Spike Analysis (CP.MP.105) (PDF)
- Distinct Procedural Modifiers (CC.PP.020) (PDF)
- Drugs of Abuse: Presumptive Testing (CP.MP.208) (PDF)
- Duplicate Primary Code Billing (CC.PP.044) (PDF)
- E&M Bundling with Lab-Radiology (CC.PP.010) (PDF)
- E&M Medical Decision-Making (CC.PP.051) (PDF)
- Endometrial Ablation (EA) (CP.MP.106) (PDF)
- Enhanced Code Editing (TX.PP.011-A) (PDF)
- Evaluation and Management (E/M) Services Billed with Treatment Room Revenue Codes (CC.PP.071) (PDF)
- Evoked Potentials (CP.MP.134) (PDF)
- Genetic and Molecular Testing Services (TX.PP.551) (PDF)
- Genitourinary Lab Testing (TX.CP.MP.307) (PDF)
- Holter Monitors (CP.MP.113) (PDF)
- Homocysteine Testing (CP.MP.121) (PDF)
- Hospital Visit Codes Billed with Labs (CC.PP.023) (PDF)
- Influenza Testing (TX.CP.MP.115) (PDF)
- Infectious Disease: Dermatologic Testing (TX.CP.MP.303) (PDF)
- Infectious Disease: Gastroenterologic Lab Testing (TX.CP.MP.304) (PDF)
- Infectious Disease: Multi-System Lab Testing (TX.CP.MP.302) (PDF)
- Infectious Disease: Respiratory Lab Testing (TX.CP.MP.301) (PDF)
- Infectious Disease: Vector-Borne and Tropical Diseases Lab Testing (TX.CP.MP.306) (PDF)
- Inpatient Only Procedures (CC.PP.018) (PDF)
- Intravenous Hydration (CC.PP.012) (PDF)
- Leveling of Emergency Room Services - Professional (CC.PP.053)
- Leveling of Emergency Room Services - Facility (CC.PP.064)
- Maximum Units of Service (CC.PP.007) (PDF)
- Measure Serum 1,25 Vitamin D (CP.MP.152) (PDF)
- Mechanical Stretch Devices (CP.MP.144) (PDF)
- Moderate Conscious Sedation (CC.PP.015) (PDF)
- Modifier DOS Validation (CC.PP.034) (PDF)
- Modifier to Procedure Code Validation (CC.PP.028) (PDF)
- Multiple CPT Code Replacement (CC.PP.033) (PDF)
- Multiple Procedure Payment Reduction (MPPR) for Diagnostic Cardiovascular Procedures (CC.PP.065) (PDF)
- NCCI Unbundling (CC.PP.031) (PDF)
- Never Paid Events (CC.PP.017) (PDF)
- New Patient (CC.PP.036) (PDF)
- Non-obstetrical and Obstetrical Transabdominal and Transvaginal Ultrasounds (CC.PP.061) (PDF)
- Not Medically Necessary Inpatient Professional Services (CC.PP.060) (PDF)
- Outpatient Consultation (CC.PP.039) (PDF)
- Physician Visit Codes Billed with Labs (CC.PP.019) (PDF)
- Place of Service Mismatch (CC.PP.063) (PDF)
- Post-Operative Visits (CC.PP.042) (PDF)
- Pre-Operative Visits (CC.PP.041) (PDF)
- Primary Care and Preventive Lab Screening (TX.CP.MP.305) (PDF)
- Professional Component Modifier (CC.PP.027) (PDF)
- Pulmonary Function Testing - CP.MP.242 (PDF)
- Pulse Oximetry with Office Visits (CC.PP.025) (PDF)
- Renal Hemodialysis (CC.PP.067) (PDF)
- Robotic Surgery (CC.PP.050) (PDF)
- Same Day Visits (CC.PP.040) (PDF)
- Sleep Studies Place of Services (CC.PP.035) (PDF)
- Status "B" Bundled Services (CC.PP.046) (PDF)
- Status "P" Bundled Services (CC.PP.049) (PDF)
- Supplies Billed on Same Day As Surgery (CC.PP.032) (PDF)
- Thyroid Testing in Pediatrics (CP.MP.154) (PDF)
- Transgender Related Services (CC.PP.047) (PDF)
- Ultrasound in Pregnancy (CP.MP.38) (PDF)
- Unbundled Professional Services (CC.PP.043) (PDF)
- Unbundled Surgical Procedures (CC.PP.045) (PDF)
- Unlisted Procedure Codes (CC.PP.009) (PDF)
- Urine Specimen Validity Testing (CC.PP.056) (PDF)
- Urodynamic Testing (CP.MP.98) (PDF)
- Vitamin D Testing in Children (CP.MP.157) (PDF)
- Wheelchair and Accessories (CC.PP.502) (PDF)
- Wireless Motility Capsule (CP.MP.143) (PDF)
Wellcare By Allwell (Medicare) Policies
- Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (MC.CP.MP.108) (PDF)
- Donor Lymphocyte Infusion (MC.CP.MP.101) (PDF)
- Endometrial Ablation (MC.CP.MP.106) (PDF)
- Implantable Wireless Pulmonary Artery Pressure Monitoring (MC.CP.MP.160) (PDF)
- Intensity Modulated Radiation Therapy (IMRT) (PDF)
- Lung Transplantation (MC.CP.MP.57) (PDF)
- Pediatric Kidney Transplant (MC.CP.MP.246) (PDF)
- Peripheral Nerve Blocks (MC.CP.MP.170) (PDF)
- Short Inpatient Hospital Stay (MC.CP.MP.182) (PDF)
- Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) (PDF)
- 30 Day Readmission (CC.PP.501) (PDF)
- Acute Care Inpatient Hospital Claims - Sepsis Diagnosis (CP.PP.073) (PDF)
- Add on Code Billed Without Primary Code (CC.PP.030) (PDF)
- Assistant Surgeon (CC.PP.029) (PDF)
- Bilateral Procedures (CC.PP.037) (PDF)
- Cerumen Removal (CC.PP.008 ) (PDF)
- Clinical Validation of Modifier 25 (CC.PP.013) (PDF)
- Clinical Validation of Modifier 59 (CC.PP.014) ) (PDF)
- Code Editing Overview (TX.CC.PP.011) (PDF)
- Cosmetic Procedures (CC.PP.024 ) (PDF)
- Distinct Procedural Modifiers (CC.PP.020) (PDF)
- Duplicate Primary Code Billing (CC.PP.044) (PDF)
- E&M Bundling (CC.PP.010) (PDF)
- E&M Medical Decision-Making (CC.PP.051) (PDF)
- Enhanced Code Editing TX.PP.011-A) (PDF)
- Genetic and Molecular Testing Services (TX.PP.551;;) (PDF)
- Genitourinary Lab Testing (TX.CP.MP.307) (PDF)
- Global Maternity Billing (CC.PP.016) (PDF)
- Hospital Visit Codes Billed with Labs (CC.PP.023) (PDF)
- C Consultation (CC.PP.038) (PDF)
- Infectious Disease: Dermatologic Testing (TX.CP.MP.303) (PDF)
- Infectious Disease: Gastroenterologic Lab Testing (TX.CP.MP.304) (PDF)
- Infectious Disease: Multi-System Lab Testing (TX.CP.MP.302) (PDF)
- Infectious Disease: Respiratory Lab Testing (TX.CP.MP.301) (PDF)
- Infectious Disease: Vector-Borne and Tropical Diseases Lab Testing (TX.CP.MP.306) (PDF)
- Inpatient Only Procedures (CC.PP.018) ) (PDF)
- Intravenous Hydration (CC.PP.012) (PDF)
- Maximum Units of Service (CC.PP.007 ) (PDF)
- Moderate Conscious Sedation (CC.PP.015) ) (PDF)
- Modifier DOS Validation ;CC.PP.034) ) (PDF)
- Modifier to Procedure Code Validation (CC.PP.028;) ) (PDF)
- Multiple CPT Code Replacement (CC.PP.033) ) (PDF)
- NCCI Unbundling (CC.PP.031) ) (PDF)
- Never Paid Events (CC.PP.017) (PDF)
- New Patient (CC.PP.036) ) (PDF)
- Non-obstetrical and Obstetrical Transabdominal and Transvaginal Ultrasounds (CC.PP.061) (PDF)
- Non-Emergent ER Services (Leveling of ER) (CC.PP.053) (PDF)
- Office Visits Billed with Treatment Rooms (CC.PP.071) (PDF)
- Outpatient Consultation (CC.PP.039;;) (PDF)
- Physician Visit Codes Billed with Labs (CC.PP.019) ) (PDF)
- Place of Service Mismatch (CC.PP.063) (PDF)
- Problem-Oriented Visits with Preventative Visits (CC.PP.057) (PDF)
- Primary Care and Preventive Lab Screening (TX.CP.MP.305) (PDF)
- Problem-Oriented Visits with Surgical Procedures (CC.PP.052) (PDF)
- Professional Component Modifier (CC.PP.027) (PDF)
- Pulse Oximetry with Office Visits (CC.PP.025) ) (PDF)
- Post-Operative Visits (CC.PP.042) ) (PDF)
- Pre-Operative Visits (CC.PP.041) (PDF)
- Renal Hemodialysis (CC.PP.067) (PDF)
- Same Day Visits (CC.PP.040) (PDF)
- Sleep Studies Place of Service (CC.PP.035) (PDF)
- Skilled Nursing Facility Leveling (CP.PP.206) (PDF)
- Status "B"Bundled Services (CC.PP.046 ) (PDF)
- Status "P" Bundled Services (CC.PP.049) (PDF)
- Supplies Billed on Same Day As Surgery (CC.PP.032) (PDF)
- Transgender Related Services (CC.PP.047 ) (PDF)
- Unbundled Professional Services (CC.PP.043) (PDF)
- Unbundled Surgical Procedures (CC.PP.045) (PDF)
- Unlisted Procedure Codes (CC.PP.009) (PDF)
- Urine Specimen Validity Testing (CC.PP.056) (PDF)
- Wheelchairs and Accessories (CC.PP.502) (PDF)
Archived Policies
- Bevacizumab (Avastin) (CP.PHAR.93) - RETIRED (Medicare February 15, 2024)(PDF)
- Cell-free Fetal DNA Testing (CP.MP.84) - RETIRED (Medicare February 15, 2024) (PDF)
- Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder (CP.BH.201) - RETIRED (Medicare February 15, 2024) (PDF)
- Diagnostic Testing Guidelines for 2019-Novel Coronavirus (CP.MP.183) - RETIRED (Medicare February 15, 2024)(PDF)
- DNA Analysis of Stool (CP.MP.125) - RETIRED (Medicare February 15, 2024) (PDF)
- Drugs of Abuse: Presumptive Testing (CP.MP.208) - RETIRED (Medicare February 15, 2024) (PDF)
- EEG in Evaluation of Headache (CP.MP.155) - RETIRED (Medicare February 15, 2024) (PDF)
- Endometrial Ablation (EA) (CP.MP.106) - RETIRED (Medicare February 15, 2024) (PDF)
- EpiFix Wound Treatment (CP.MP.140) - RETIRED (Medicare February 15, 2024) (PDF)
- Evoked Potentials (CP.MP.134) - RETIRED (Medicare February 15, 2024) (PDF)
- Experimental Technologies (CP.MP.36) - RETIRED (Medicare February 15, 2024) (PDF)
- Fecal Calprotectin Assay (CP.MP.135) - RETIRED (Medicare February 15, 2024) (PDF)
- FeNo Testing (CP.MP.103) - RETIRED (Medicare February 15, 2024) (PDF)
- Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (CP.MP.209) - RETIRED (Medicare February 15, 2024) (PDF)
- H Pylori Testing (CP.MP.153) - RETIRED (Medicare February 15, 2024) (PDF)
- Homocysteine Testing (CP.MP.121) - RETIRED (Medicare February 15, 2024) (PDF)
- Hyperemesis Gravidarum Treatment (CP.MP.34) - RETIRED (Medicare February 15, 2024) (PDF)
- Inhaled Nitric Oxide (CP.MP.87) - RETIRED (Medicare February 15, 2024) (PDF)
- Laser Skin Treatment (CP.MP.123) - RETIRED (Medicare February 15, 2024) (PDF)
- Mechanical Stretch Devices (CP.MP.144) - RETIRED (Medicare February 15, 2024) (PDF)
- Monitored Anesthesia Care for Gastrointestinal Endoscopy (CP.MP.161) - RETIRED (Medicare February 15, 2024) (PDF)
- Neonatal Sepsis Management (CP.MP.85) - RETIRED (Medicare February 15, 2024) (PDF)
- Obstetrical Home Care Programs (CP.MP.91) - RETIRED (Medicare February 15, 2024) (PDF)
- Polymerase Chain Reaction Respiratory Viral Panel Testing (CP.MP.181) - RETIRED (Medicare February 15, 2024) (PDF) PROM Testing (CP.MP.149) (PDF)
- Proton and Neutron Beam Therapy (CP.MP.70) - RETIRED (Medicare February 15, 2024) (PDF)
- Reduction Mammoplasty and Gynecomastia Surgery (CP.MP.51) (PDF)
- Testing for Select Genitourinary Conditions (CP.MP.97) - RETIRED (Medicare February 15, 2024)(PDF)
- Transcranial Magnetic Stimulation for Treatment Resistant Major Depression (CP.BH.200) - RETIRED (Medicare February 15, 2024) (PDF)
- Ultrasound in Pregnancy (CP.MP.38) - RETIRED (Medicare February 15, 2024) (PDF)
- Urodynamic Testing (CP.MP.98) - RETIRED (Medicare February 15, 2024) (PDF)
- Wheelchair Seating (CP.MP.99) - RETIRED (Medicare February 15, 2024) (PDF)
- Wireless Motility Capsule (CP.MP.143) - RETIRED (Medicare February 15, 2024) (PDF)
- Selective Dorsal Rhizotomy (CP.MP.174) (RETIRED - Medicaid January 17, 2024) (PDF)
- C1 Esterase Inhibitors (Berinert Cinryze Haegarda Ruconest) (CP.PHAR.202) (RETIRED - Ambetter January 2, 2024) (PDF)
- Lanadelumab-fylo (Takhzyro) (CP.PHAR.396) (RETIRED - Ambetter January 2, 2024) (PDF)
- Berotralstat (Orladeyo) (CP.PHAR.485) (RETIRED - Ambetter January 2, 2024) (PDF)
- Linaclotide (Linzess) (CP.PMN.71) (RETIRED - Ambetter January 2, 2024) (PDF)
- Tofersen (Qalsody) (CP.PHAR.116) - (RETIRED Medicaid December 1, 2023) (PDF)
- Etranacogene Dezaparvovec (Hemgenix) (CP.PHAR.580) - (RETIRED Medicaid December 1, 2023) (PDF)
- Vestronidase alfa-vjbk (Mepsevii) (CP.PHAR.374) - (RETIRED - Medicaid December 1, 2023) (PDF)
- Sildenafil (Revatio) (CP.PHAR.197) - (RETIRED Medicaid August 1, 2023) (PDF)
- Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (CP.PHAR.168) (RETIRED - Ambetter August 1, 2023 (PDF)
- Durable Medical Equipment (TX.CP.MP.552) (RETIRED - Medicaid July 19, 2023) (PDF)
- Selpercatinib (Retevmo) (CP.PHAR.478) (RETIRED Medicaid June 1, 2023) (PDF)
- Sodium Phenylbutyrate-Taurursodiol (Relyvrio) (RETIRED Medicaid June 1, 2023) (CP.PHAR.584) (PDF)
- Ferric Gluconate (Ferrlecit) (CP.PHAR.166) (RETIRED Medicaid and Ambetter June 1, 2023) (PDF)
- Iron Sucrose (Venofer) (CP.PHAR.167) (RETIRED Medicaid and Ambetter June 1, 2023) (PDF)
- Casirivimab and imdevimab (REGN-COV2) (RETIRED Medicaid and Ambetter June 1, 2023) (CP.PHAR.520) (PDF)
- Bamlanivimab-etesevimab (LY-CoV555-LY-CoV016) (CP.PHAR.532) (RETIRED Medicaid and Ambetter June 1, 2023) (PDF)
- Sotrovimab (VIR-7831) (CP.PHAR.541) (RETIRED Medicaid and Ambetter June 1, 2023) (PDF)
- Tixagevimab-Cilgavimab (Evusheld) (CP.PHAR.571) (RETIRED Medicaid and Ambetter June 1, 2023) (PDF)
- Ultrasound in Pregnancy (CP.MP.38) (RETIRED Ambetter May 17, 2023) (PDF)
- Testing for Select Genitourinary Conditions (CP.MP.97) (RETIRED Ambetter and Medicaid May 17, 2023) (PDF)
- Endometrial Ablation (CP.MP.106) (RETIRED Ambetter May 17, 2023) (PDF)
- Bronchial Thermoplasty (CP.MP.110) (RETIRED Ambetter and Medicaid May 17, 2023) (PDF)
- Homocysteine Testing (CP.MP.121) (PDF)
- Laser Therapy for Skin Conditions (CP.MP.123) (RETIRED Ambetter May 17, 2023) (PDF)
- Low-frequency Ultrasound and Noncontact Wound Therapy (CP.MP.139) (RETIRED Ambetter and Medicaid May 17, 2023) (PDF)
- Polymerase Chain Reaction Respiratory Viral Panel Testing (CP.MP.181) (RETIRED Ambetter May 17, 2023) (PDF)
- Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (CP.MP.209) (RETIRED Ambetter and Medicaid May 17, 2023) (PDF)
- Pulmonary Function Testing (CP.MP.242) (RETIRED Ambetter May 17, 2023) (PDF)
- Holter Monitors (CP.MP.113) (RETIRED Ambetter May 17, 2023) (PDF)
- Evoked Potentials (CP.MP.134) (RETIRED Ambetter May 17, 2023) (PDF)
- Incontinence Supplies (TX.CP.MP.508) (RETIRED Medicaid June 1, 2023) (PDF)
Allergy Testing and Therapy (TX.CP.MP.100) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF)
Antithrombin III (Thrombate III, Atryn) (CP.MP.179) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF)- Burn Surgery (CP.MP.186) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF)
- Cell-free Fetal DNA Testing (CP.MP.84) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF)
- Drugs of Abuse: Presumptive Testing (CP.MP.208) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF)
- EpiFix Wound Treatment (CP.MP.140) (RETIRED Medicaid May 4, 2023) (PDF)
- Essure Removal (CP.MP.131) (RETIRED Ambetter May 4, 2023) (PDF)
- Evinacumab-dgnb (Evkeeza) (CP.PHAR.511) (PDF)
- Fertility Preservation (CP.MP.130) (PDF)
- Fixed Wing Air Transportation (CP.MP.175) (RETIRED Medicaid May 4, 2023) (PDF)
- Fractional Exhaled Nitric Oxide (CP.MP.103) (RETIRED Medicaid May 4, 2023) (PDF)
- Global Maternity Billing (CC.PP.016) (RETIRED Medicaid May 4, 2023) (PDF)
- Functional MRI (CP.MP.43) (RETIRED Ambetter May 4, 2023) (PDF)
- Home Births (CP.MP.136) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF)
- Hyperemesis Gravidarum Treatment (CP.MP.34) (RETIRED Ambetter May 4, 2023) (PDF)
- Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (CP.MP.180) (RETIRED Medicaid May 4, 2023) (PDF)
- Long Term Care Placement Criteria (CP.MP.71) (RETIRED Medicaid May 4, 2023) (PDF)
Multiple Sleep Latency Testing (CP.MP.24) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF) - Neuromuscular Electrical Stimulation (CP.MP.48) (RETIRED Medicaid May 4, 2023) (PDF)
Non-Invasive Home Ventilator (CP.MP.184) - for CHIP only (RETIRED Medicaid May 4, 2023) (PDF) - Private Duty Nursing (TX.CP.MP.520) (RETIRED Ambetter May 4, 2023) (PDF)
- Proton and Neutron Beam Therapy (CP.MP.70) (RETIRED Medicaid May 4, 2023) (PDF)
- Radiofrequency Ablation of Uterine Fibroids (CP.MP.187) (RETIRED Ambetter May 4, 2023) (PDF)
- Renal Hemodialysis (CC.PP.067) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF)
- Selective Dorsal Rhizotomy (RETIRED Ambetter May 4, 2023) (CP.MP.174) (PDF)
- Short Inpatient Hospital Stay (TX.CP.MP.582) (RETIRED Ambetter May 4, 2023) (PDF)
Sickle Cell Disease Observation (CP.MP.88) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF) - Therapy Services (PT, OT, ST) (CP.MP.49) (RETIRED Medicaid May 4, 2023) (PDF)
- Transcatheter Closure of Patent Foramen Ovale (CP.MP.151) (RETIRED Ambetter and Medicaid May 4, 2023) (PDF)
Wheelchair Seating (CP.MP.99) (RETIRED Medicaid May 4, 2023) (PDF)Hydroxyprogesterone caproate (Makena) (CP.PHAR.14) - RETIRED (Ambetter April 10, 2022) (PDF) - Makena Clinical Criteria for Authorization via Medical Benefit (TX.PHAR.15) - RETIRED (Medicaid April 10, 2022) (PDF)
- Hyperemesis Gravidarum Treatment (CP.MP.34) - RETIRED (Medicaid and Ambetter March 22, 2023 (PDF)
- Tobramycin (Bethkis, Kitabis Pak, TOBI, TOBI Podhaler) - RETIRED (Medicaid March 1, 2023) (CP.PHAR.211) (PDF)
- Protein C Concentrate Human (Ceprotin) (CP.PHAR.330) - RETIRED (Medicaid March 1, 2023) (PDF)
Enzalutamide (Xtandi) (HIM.PA.164) - RETIRED (Ambetter March 1, 2023) (PDF) - Evinacumab-dgnb (Evkeeza) (CP.PHAR.511) - RETIRED (Ambetter March 1, 2023) (PDF)
- Latanoprostene Bunod (Vyzulta) (CP.PMN.108)- RETIRED (Ambetter March 1, 2023) (PDF)
- Netarsudil (Rhopressa), Netarsudil/Latanoprost (Rocklatan) (CP.PMN.118)- RETIRED (Ambetter March 1, 2023) (PDF)
- Pegaptanib (Macugen) (CP.PHAR.185)- RETIRED (Medicaid and Ambetter March 1, 2023) (PDF)
- Genetic and Pharmacogenetic Testing (CP.MP.89) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing: Aortopathies and Connective Tissue Disorders (CP.MP.215) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Cardiac Disorders (CP.MP.216) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing: Dermatologic Conditions (CP.MP.217) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Epilepsy, Neurodegenerative, and Neuromuscular Disorders (CP.MP.218) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (CP.MP.219) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Eye Disorders (CP.MP.220) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Gastroenterologic Disorders (non-cancerous) (CP.MP.221)
- Genetic Testing General Approach to Genetic Testing (CP.MP.222) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Hearing Loss (CP.MP.223) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Hematologic Condition (non-cancerous) (CP.MP.224) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Hereditary Cancer Susceptibility (CP.MP.225) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Immune, Autoimmune, and Rheumatoid Disorders (CP.MP.226) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Lung Disorders (CP.MP.228) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Metabolic, Endocrine, and Mitochondrial Disorders (CP.MP.229) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (CP.MP.230) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing for Non-Invasive Prenatal Screening (NIPS) (CP.MP.231) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Pharmacogenetics (CP.MP.232) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Preimplantation Genetic Testing (CP.MP.233) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Prenatal and Preconception Carrier Screening (CP.MP.234) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Prenatal Diagnosis (Via Amniocentises, CVS, or PUBS) and Pregnancy Loss (CP.MP.235) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Genetic Testing Skeletal Dysplasia and Rare Bone Disorders (CP.MP.236) - RETIRED (Medicaid and Ambetter February 20, 2023 (PDF)
- Patisiran (Onpattro) (CP.PHAR.395) - RETIRED (Medicaid February 7, 2023) (PDF)
- PROM Testing (CP.MP.149) - RETIRED (Medicaid and Ambetter January 16, 2023) (PDF)
- Ambulatory EEG (CP.MP.96) - RETIRED (Medicare January 16, 2023) (PDF)
- Measure Serum 1,25 Vitamin D (CP.MP.152) - RETIRED (Medicare January 16, 2023) (PDF)
- Holter Monitors (CP.MP.113) - RETIRED (Medicare January 16, 2023) (PDF)
- Genetic Testing (TX.CP.MP.531) - RETIRED (Medicaid January 1, 2023) (PDF)
- Pharmacogenetic Testing - RETIRED (Medicaid January 1, 2023) (TX.CP.MP.528) (PDF)
- Podiatry Services (TX.CP.MP.527) - RETIRED (Medicaid October 17, 2022) (PDF)
- Compounded Medications (CP.PCH.27) - RETIRED (Ambetter September 1, 2022) (PDF)
- Lactitol (Pizensy) (CP.PMN.241) - RETIRED (Ambetter September 1, 2022) (PDF)
- Valproate (Depacon) (CP.PHAR.429) -- RETIRED (Medicaid and Ambetter September 1, 2022) (PDF)
- Home Cardiorespiratory Monitors (TX.CP.MP.501) - RETIRED (Medicaid August 15, 2022)(PDF)
- Nebivolol (Bystolic) (HIM.PA.131) - RETIRED (Ambetter June 1, 2022) (PDF)
- Natalizumab (Tysabri) (HIM.PA.SP17) - RETIRED (Ambetter June 1, 2022) (PDF)
- Lorcaserin (Belviq, Belviq XR) (CP.PCH.03) - RETIRED (Ambetter June 1, 2022) (PDF)
- Thymus Transplantation (CP.MP.189) - RETIRED (Medicaid and Ambetter April 28, 2022)(PDF)
- Ambulatory EEG (CP.MP.96) (Medicaid and Ambetter April 28, 2022) (PDF)
- Lesinurad (Zurampic), Lesinurad-allopuriNol (Duzallo) (CP.PMN.150) - RETIRED (Ambetter March 1, 2022) (PDF)
- Cerliponase alfa (Brineura) (TX.PHAR.46) - RETIRED (Medicaid January 24, 2022)(PDF)
- Ivermectin (Sklice) (HIM.PA.124) - RETIRED (Ambetter February 1, 2022) (PDF)
- Velaglucerase Alfa (VPRIV) (CP.PHAR.163) - RETIRED (Ambetter February 1, 2022) (PDF)
- Taliglucerase Alfa (Elelyso) (CP.PHAR.157) - Effective January 15, 2021 (PDF)
- Chlorambucil (Leukeran) (HIM.PA.SP59) - RETIRED (Ambetter February 1, 2022) (PDF)
- Anifrolumab-fnia (Saphnelo) (CP.PHAR.551) - RETIRED (Medicaid February 1, 2022)
- Fractional Exhaled Nitric Oxide (CP.MP.103) (PDF) - RETIRED (Medicaid January 26, 2022)
- Pegademase Bovine (Adagen) (CP.PHAR.392) - RETIRED (Medicaid and Ambetter December 1, 2021 (PDF)
- Human Growth Hormone (Somapacitan, Somatropin) (CP.PCH.39) - RETIRED (Ambetter December 1, 2021) (PDF)
- Bremelanotide (Vyleesi) (CP.PHAR.434) - RETIRED (Ambetter December 1, 2021) (PDF)
- DNA Analysis of Stool (CP.MP.125) - RETIRED (Medicaid and Ambetter November 18, 2021) (PDF)
- Handling Authorizations for Transportation (TX.UM.10.07) - RETIRED (Medicaid November 1, 2021 (PDF)
- Corticosteroid Intravitreal Implants (Iluvien, Ozurdex, Retisert, Yutiq) (CP.PHAR.385) (PDF) - RETIRED (Medicaid October 18, 2021)
- Abatacept (Orencia) (CP.PHAR.241) (PDF) - RETIRED (Medicaid October 18, 2021)
- Alglucosidase Alfa (Lumizyme) (CP.PHAR.160) (PDF) - RETIRED (Medicaid October 18, 2021)
- Benralizumab (Fasenra) (CP.PHAR.373) (PDF) - RETIRED (Medicaid October 18, 2021)
- Brexucabtagene Autoleucel (Tecartus) (CP.PHAR.472) (PDF) - RETIRED (Medicaid October 18, 2021)
- Brexucabtagene Autoleucel (Tecartus) (CP.PHAR.472) (PDF) - RETIRED (Medicaid October 18, 2021)
- Crizanlizumab-tmca (Adakveo) (CP.PHAR.449) (PDF) - RETIRED (Medicaid October 18, 2021)
- Emapalumab-lzsg (Gamifant) (CP.PHAR.402) - RETIRED (Medicaid October 18, 2021) (PDF)
- Treprostinil (Orenitram, Remodulin, Tyvaso) (CP.PHAR.199) - RETIRED (Medicaid October 18, 2021) (PDF)
- Ibalizumab-uiyk (Trogarzo) (CP.PHAR.378) - RETIRED (Medicaid October 18, 2021) (PDF)
- Inebilizumab-cdon (Uplizna) (CP.PHAR.458) - RETIRED (Medicaid October 18, 2021) (PDF)
- Luspatercept-aamt (Reblozyl) (CP.PHAR.450) - RETIRED (Medicaid October 18, 2021)(PDF)
- Mepolizumab (Nucala) (CP.PHAR.200) - RETIRED (Medicaid October 18, 2021) (PDF)
- Mogamulizumab-kpkc (Poteligeo) (CP.PHAR.139) - RETIRED (Medicaid October 18, 2021) (PDF)
- Moxetumomab Pasudotox-tdfk (Lumoxiti) (CP.PHAR.398) - RETIRED (Medicaid October 18, 2021)(PDF)
- Omalizumab (Xolair) (CP.PHAR.01) - RETIRED (Medicaid October 18, 2021) (PDF)
- Patisiran (Onpattro) (CP.PHAR.395) - RETIRED (Medicaid October 18, 2021) (PDF)
- Reslizumab (Cinqair) (CP.PHAR.223) - RETIRED (Medicaid October 18, 2021) (PDF)
- Teprotumumab (Tepezza) (CP.PHAR.465) - Effective 9/16/2020 (PDF)
- Vestronidase alfa-vjbk (Mepsevii) (CP.PHAR.374) - Effective January 9, 2018 (PDF)
- Plecanatide (Trulance) (CP.PMN.87) - RETIRED (Ambetter Septebmer 23, 2021)
- Sipuleucel-T (Provenge) (CP.PHAR.120) - RETIRED (Ambetter August 2, 2021)
- Carrier Screening in Pregnancy (CP.MP.83) (PDF) - RETIRED (Medicaid July 30, 2021)
- Evolocumab (Repatha) (CP.PHAR.123) - Effective 10/1/2015 (PDF) – RETIRED (Ambetter June 1, 2021)
- Continuous Insulin Delivery Systems (V-Go, Omnipod) (CP.PHAR.505) - Effective 12/1/2020 (PDF) – RETIRED (Ambetter June 1, 2021)
- Prucalopride (Motegrity) (CP.PMN.194) - Effective January 29, 2019 (PDF) – RETIRED (Ambetter June 1, 2021)
- Pralsetinib (Gavreto) (CP.PHAR.514) - Effective 2/1/2021 (PDF) – RETIRED (Ambetter June 1, 2021)
- Lemborexant (Dayvigo) (CP.PMN.233) - Effective 6/1/2020 (PDF) – RETIRED (Ambetter June 1, 2021)
- Budesonide (Pulmicort Respules) (HIM.PA.48) - Effective 9/1/2018 (PDF) – RETIRED (Ambetter May 3, 2021)
- Budesonide/Glycopyrrolate/Formoterol Fumarate (Breztri Aerosphere) (HIM.PA.150) - Effective 12/1/2020 (PDF) – RETIRED (Ambetter May 3, 2021)
- Buprenorphine-Naloxone (Bunavail, Cassipa, Suboxone) (HIM.PA.35) - Effective 2/1/2017 (PDF) – RETIRED (Ambetter May 3, 2021)
- Ciclesonide (Alvesco) (HIM.PA.65) - Effective 11/17/2020 (PDF) – RETIRED (Ambetter May 3, 2021)
- Indacaterol/Glycopyrrolate (Utibron Neohaler) (HIM.PA.102) - Effective 1/1/2021 (PDF) – RETIRED (Ambetter May 3, 2021)
- Aclidinium/Formoterol (Duaklir Pressair) (CP.PCH.23) - Effective 9/16/2020 (PDF) – RETIRED (Ambetter 3/1/2021)
- Eptinezumab (Vyepti) (CP.PCH.29) - Effective 6/1/2011 (PDF) – RETIRED (Ambetter 1/1/2021)
- Fremanezumab-vfrm (Ajovy) (CP.PCH.17) - Effective 3/1/2020 (PDF) – RETIRED (Ambetter 1/1/2021)
- Applied Behavioral Analysis for Autism (CP.MP.104) (PDF) – RETIRED (Ambetter 12/30/2020)
- Cell-free Fetal DNA Testing (CP.MP.84) (PDF) – RETIRED (Ambetter 12/30/2020)
- Neonatal Abstinence Syndrome Guidelines (CP.MP.86) (PDF) – RETIRED (Ambetter 12/30/2020)
- Genetic Testing (TX.CP.MP.531) (PDF) – RETIRED (Medicaid and CHIP 12/30/2020)
- Enteral Nutrition (TX.CP.MP.550) (PDF) – RETIRED (Medicaid and CHIP 12/30/2020)
- Magnetoencephalography (TX.CP.MP.570) – RETIRED (Medicaid and CHIP 12/30/2020)
- Antithymocyte Globulin (Thymoglobulin, Atgam) (HIM.PA.16) - RETIRED (Ambetter - 12/1/2020)
- Ciprofloxacin/Dexamethasone (Ciprodex) (HIM.PA.120) - Effective 12/1/2017 (PDF) - RETIRED (Ambetter - 12/1/2020)
- Ciprofloxacin/Fluocinolone (Otovel) (HIM.PA.14) - Effective 9/4/2018 (PDF) - RETIRED (Ambetter - 12/1/2020)
- Clindamycin (Evoclin) (HIM.PA.21) - Effective 8/28/2018 (PDF) - RETIRED (Ambetter - 12/1/2020)
- Clindamycin Phosphate/Benzoyl Peroxide (BenzaClin) (HIM.PA.31) - Effective 12/1/2018 (PDF) - RETIRED (Ambetter - 12/1/2020)
- Colesevelam (WelChol) (HIM.PA.121) - Effective 12/1/2017 (PDF) - RETIRED (Ambetter - 12/1/2020)
- Insulin Infusion Pump (Omnipod, Omnipod DASH) (CP.PHAR.420) - Effective 4/23/2019 (PDF) - RETIRED (Ambetter - 12/1/2020)
- Lomustine (Gleostine) (HIM.PA.19) - Effective 8/28/2018 (PDF) - RETIRED (Ambetter - 12/1/2020)
- Mesalamine (Apriso) (HIM.PA.42) - Effective 9/4/2018 (PDF) - RETIRED (Ambetter - 12/1/2020)
- Topical Diclofenac (Solaraze, Flector) (HIM.PA.123) (PDF) - RETIRED (Ambetter - 12/1/2020)
- Apomorphine (Apokyn) (CP.PCH.14) (PDF) - RETIRED (Ambetter - 11/17/2020)
- Brivaracetam (Briviact) (HIM.PA.07) (PDF) - RETIRED (Ambetter - 11/17/2020)
- Daclatasvir (Daklinza) (CP.PCH.15) (PDF) - RETIRED (Ambetter - 11/17/2020)
- Elbasvir/Grazoprevir (Zepatier) (CP.PCH.16) (PDF) - RETIRED (Ambetter - 11/17/2020)
- Ledipasvir/Sofosbuvir (Harvoni) (CP.PCH.19) (PDF) - RETIRED (Ambetter - 11/17/2020)
- Sofosbuvir (Sovaldi) (CP.PCH.20) (PDF) - RETIRED (Ambetter - 11/17/2020)
- Topical Diclofenac (Solaraze, Flector) (HIM.PA.123) (PDF) - RETIRED (Ambetter - 11/17/2020)
- Trigger Point Injections for Pain Management (CP.MP.169) (PDF) - RETIRED (Ambetter - 10/30/2020)
- Facet Joint Interventions for Pain Management (CP.MP.171) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 10/1/2020)
- Fecal Incontinence Treatments (CP.MP.137) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 10/1/2020)
- Reduction Mammoplasty and Gynecomastia Surgery (CP.MP.51) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 10/1/2020)
- Neonatal Sepsis Management Guidelines (CP.MP.85) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 10/1/2020)
- Physician’s Office Lab Testing (CC.PP.055) (PDF) – IMPLEMENTATION CANCELLED
- Monitored Anesthesia Care for Gastrointestinal Endoscopy - Effective 1/15/19 (CP.MP.161) PDF) - RETIRED (Medicaid and CHIP - 7/18/2019, Medicare - 7/22/2019, MarketPlace - 7/22/2019)
- Rituximab - Effective 11/1/2017 (CP.PHAR.260) (PDF) - RETIRED (Medicaid and CHIP, Medicare, Ambetter - 1/1/ 2019)
- Halobetasol-Tazarotene (Duobrii) (CP.PMN.208) (PDF) - RETIRED (Ambetter - 6/1/2020)
- Naloxone (Evzio) (CP.PMN.139) (PDF) - RETIRED (Ambetter - 6/1/2020)
- Sodium Zirconium Cyclosilicate (Lokelma) (CP.PMN.163) (PDF) - RETIRED (Ambetter - 6/1/2020)
- Digital Breast Tomosynthesis (DBT) (CP.MP.90) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 10/5/2018)
- Fecal Calprotectin Assay (CP.MP.135) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 12/14/2018)
- Assertive Community Treatment (TX.CP.MP.548) (PDF) - RETIRED (Medicaid and CHIP - 3/20/2020)
- Home Telemonitoring Services (TX.CP.MP.547) (PDF) - RETIRED (Medicaid and CHIP - 3/18/2020)
- Standard Manual Wheelchair or Standard Power Wheeled Mobility Systems (TX.CP.MP.519) (PDF) - RETIRED (Medicaid and CHIP - 4/15/2020)
- Emtricitabine-Tenofovir (Truvada) (HIM.PA.78) - RETIRED (Ambetter - 9/16/2020)
- Glecaprevir/Pibrentasvir (Mavyret) (CP.PCH.18) - RETIRED (Ambetter - 9/16/2020)
- Sofosbuvir/Velpatasvir (Epclusa) (CP.PCH.21) - RETIRED (Ambetter - 9/16/2020)
- Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (CP.PCH.22) - RETIRED (Ambetter - 9/16/2020)
- Erenumab-aaoe (Aimovig) (CP.PHAR.128) - Effective 7/10/2018 (PDF) - RETIRED (Ambetter - 10/6/2020)
- Galcanezumab-gnlm (Emgality) (CP.PCH.24) - Effective 1/1/2020 (PDF) - RETIRED (Ambetter - 10/6/2020)
- Oncology Molecular Analysis of Solid Tumors and Hematologic Malignancies (CP.MP.241) (PDF) - RETIRED (Ambetter, Medicaid and CHIP – 02/26/2024)
- Oncology Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (CP.MP.239) (PDF) - RETIRED (Ambetter, Medicaid and CHIP – 02/26/2024)
- Oncology Algorithmic Testing (CP.MP.237) (PDF) - RETIRED (Ambetter, Medicaid and CHIP – 02/26/2024)
- Oncology Cytogenetic Testing (CP.MP.240) (PDF) - RETIRED (Ambetter, Medicaid and CHIP – 02/26/2024)
- Oncology Cancer Screening (CP.MP.238) (PDF) - RETIRED (Ambetter, Medicaid and CHIP – 02/26/2024)
- Hyaluronate Derivatives (CP.PHAR.05) (PDF) - RETIRED (Medicaid and CHIP - 03/01/2024)
- Goserelin Acetate (Zoladex) (CP.PHAR.171) (PDF) - RETIRED (Medicaid and CHIP - 03/01/2024)
- Hyperemesis Gravidarum Treatment (TX.CP.MP.534)(PDF) - RETIRED (Medicaid and CHIP - 03/20/2024)
- Cranial Remolding Orthosis (TX.CP.MP.516) (PDF) - RETIRED (Medicaid and CHIP - 04/15/2024)
- Home Phototherapy (TX.CP.MP.510) (PDF) - RETIRED (Medicaid and CHIP - 04/15/2024)
- H Pylori Testing (CP.MP.153) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 06/01/2024)
- Testing for Select Genitourinary Conditions (CP.MP.97) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 06/01/2024)
- Polymerase Chain Reaction Respiratory Viral Panel Testing (CP.MP.181) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 06/01/2024)
- Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (CP.MP.209) (PDF) - RETIRED (Ambetter, Medicaid and CHIP - 06/01/2024)
- Transcatheter Closure of Patent Foramen Ovale (CP.MP.151) (PDF) - RETIRED (Medicaid and CHIP - 11/20/2024)
- Burn Surgery (CP.MP.186) (PDF) - RETIRED (Medicaid and CHIP - 12/10/2024)
- Discography (CP.MP.115) (PDF) - RETIRED (Medicaid and CHIP - 12/10/2024)
- Gender-Affirming Procedures (CP.MP.95) (PDF) - RETIRED (Medicaid and CHIP - 12/10/2024)
- Home Birth (CP.MP.136) (PDF) - RETIRED (Medicaid and CHIP - 12/10/2024)
- Intensity-Modulated Radiotherapy (CP.MP.69) (PDF) - RETIRED (Medicaid and CHIP - 12/10/2024)
- Intradiscal Steroid Injections for Pain Management (CP.MP.167) (PDF) - RETIRED (Medicaid and CHIP - 12/10/2024)
- Kidney Disorders (CP.MP.227) - RETIRED (Medicaid and CHIP - 12/10/2024)
- Multiple Sleep Latency Testing (CP.MP.24) (PDF) - RETIRED (Medicaid and CHIP - 12/10/2024)
- Renal Hemodialysis (CC.PP.067) (PDF) - RETIRED (Medicaid and CHIP - 12/10/2024)
- Repair of Nasal Valve Compromise (CP.MP.210) (PDF) - RETIRED (Medicaid and CHIP - 12/10/2024)